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INSIGHTS INTO DETERMINANTS THAT CONTRIBUTE TO COLONIZATION, 
VIRULENCE AND ANTIBIOTIC RESISTANCE IN ENTEROCOCCI 
 
Maria Camila Montealegre, MS. 
Advisory Professor: Barbara E. Murray, MD. 
 
Enterococcus faecalis and Enterococcus faecium are increasingly common as causative 
agents of human infections, many of which are very difficult to treat due to multi-drug 
resistance. The work presented in the first part of this dissertation elucidates a 
mechanism for the regulation of pilus expression. I showed that ATT is the initiation 
codon of ebpA, the first gene of an operon that codes for the endocarditis and biofilm-
associated pili (Ebp), a recognized virulence factor in E. faecalis. The presence of this 
rare start codon downregulates EbpA translation and protein levels, diminishing biofilm 
and binding abilities of E. faecalis, as compared to an engineered ATG codon. My 
studies also extended to the ortholog of Ebp in E. faecium, known as the E. faecium pili 
(Emp), where the role of each Emp subunit in biofilm formation, adherence and 
experimental infection was demonstrated. This study highlighted the relevance of the tip 
subunit, EmpA, in pilus biogenesis and pilus-associated functions. Due to the rising 
clinical importance of E. faecium and the fact that enterococcal infections are commonly 
preceded by intestinal colonization, the second part of this dissertation focused on the 
dynamics of gastrointestinal tract (GIT) colonization of the three known E. faecium 
clades. This work found that clade B, composed of strains that are part of the normal 
human microbiota, outcompeted most of the clade A strains, which include strains linked 
to human infections or associated with animals, when present together in a mouse 
model of GIT colonization. Last, I demonstrated that the pbp5 gene, part of the E. 
faecium core genome that shows sequence variation between the clades and encodes a 
 vii 
penicillin binding protein important for ȕ-lactam resistance, is differentially expressed 
between strains, with higher PBP5 protein levels in clade A ampicillin-resistant strains as 
compared to clade B and subclade A2 ampicillin-susceptible strains. Furthermore, I 
found evidence that there are extensive differences within the region upstream of pbp5 
among the clades that correlate with the differential abundance of PBP5 and ampicillin 
resistance. Together these studies provide further insight into determinants that 
contribute to colonization, virulence and resistance in enterococci.  
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CHAPTER 1. BACKGROUND 
  
  
2 
1.1. Scope of this chapter 
The information presented in this chapter (Chapter 1. Background) is focused on 
certain aspects of the biology of Enterococcus faecalis and E. faecium that provide a 
framework to understand the content of this dissertation. This dissertation is divided into 
two parts: 
 
Insights into enterococcal pili and their association with virulence - includes 
two chapters, Chapter 2 and Chapter 3. These chapters are focused on the study of 
one class of virulence determinants, named the endocarditis- and biofilm-associated 
pilus (Ebp) in E. faecalis and the corresponding Enterococcus faecium pilus (Emp).  
 
Defining the contribution of E. faecium clade types to gastrointestinal tract 
(GIT) colonization and ampicillin resistance - includes two chapters, Chapter 4 and 
Chapter 5. These chapters are centered on studying the GIT colonization dynamics of 
the different E. faecium lineages and the contribution of penicillin-binding protein 5 
(PBP5) levels to ampicillin resistance.  
 
1.2. The genus Enterococcus 
The genus Enterococcus, initially classified as part of the genus Streptococcus (1) 
and now composed of over 50 species (2), consist of Gram-positive, low GC, non-spore 
forming facultative anaerobes (3-5). Species from this genus are found in a variety of 
environments including soil, water, plants and the gastrointestinal tracts (GITs) of 
mammals, insects and nematodes (3). In addition, certain enterococcal strains have 
been widely used in the food industry and as probiotics, extending further their 
  
3 
distribution (6). Enterococci have been proven to survive and grow in harsh conditions, 
including a wide range of pHs, temperatures and salt concentrations (3, 5).  
 
1.3. Epidemiology and antibiotic resistance 
Enterococcus species, common commensal bacteria, were recognized as 
occasional causes of infections in the past; however, over the past few decades, the 
number of infections attributed to members of this genus has increased (5) and 
nowadays enterococci rank as important pathogens in the healthcare setting (7). E. 
faecalis and E. faecium are the enterococcal species most frequently found in the GIT of 
humans and are also the most relevant species at the clinical level (8). In the USA, 
enterococci began to emerge as a common cause of infection in hospitals during the 
1970s; at that time, E. faecalis caused 90 to 95% of enterococcal infections (4, 5). Since 
the 1990s, the species E. faecium has partially displaced E. faecalis, and now accounts 
for approximately 38% of all the enterococcal infections (4, 5, 7).  
 
Enterococci are well known for their intrinsic resistance to different antibiotics such 
as cephalosporins and aminoglycosides (4, 9). In addition, some enterococci have 
acquired other clinically important resistances via mutation of preexisting genetic 
elements; this appears to be the case of high-level ampicillin resistance in E. faecium, 
which is associated with mutations in the gene that encodes the low-affinity PBP5 
(discussed later) (9). Enterococci have also acquired resistance determinants by means 
of horizontal gene transfer, a particularly common phenomenon in this genus. An 
example is the acquisition of the vancomycin resistance gene clusters (10). Vancomycin 
resistance was first reported in E. faecium in two European countries in 1986 (11, 12) 
and, although it occurs also in E. faecalis and other enterococcal species, the vast 
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majority of vancomycin resistant enterococci (VRE) are E. faecium (9). Within E. 
faecium, it appears that vancomycin resistance initially emerged in different lineages in 
the USA and in Europe. In the USA, VRE were and continue to be prevalent in hospitals 
(7) and the van resistance determinants mainly spread in E. faecium lineages that are 
highly resistant to ampicillin and remarkably adapted to the hospital environment (13, 
14). In contrast, in Europe, VRE was first prevalent in farm animals and healthy 
individuals in an ampicillin-susceptible background (13, 14). However, Europe has also 
seen a rise in VRE infections since the early 2000s (14). Furthermore, resistance to 
newer antibiotic therapies, including linezolid and daptomycin, has been reported in 
some enterococcal strains, compromising further the ability to treat these already 
multidrug-resistant pathogens (5).  
 
1.4. Colonization and infections caused by enterococci 
Colonization of the GIT is usually recognized as the first step towards infection with 
many antibiotic resistant bacteria, including VRE (15, 16). Indeed, in patients with 
compromised immune systems due to pre-bone marrow transplant regimens, 
bloodstream infections by VRE are usually preceded by domination of the microbiota by 
Enterococcus (15, 16). Different studies, using mouse models of GIT colonization, have 
demonstrated that antibiotic treatment alters the gut microbiota diversity and allows VRE 
to displace the normal microbiota of the small and large intestine (15, 17, 18). In fact, 
depletion of Gram-negative bacteria by antibiotic treatment was shown to cause a 
decrease in the production of antimicrobial peptides, such as RegγȖ, by Paneth and 
epithelial cells of the mouse small intestine (19). RegγȖ is a C-type lectin that selectively 
targets Gram-positive bacteria; therefore, decreased production of this factor serves to 
facilitate VRE colonization and overgrowth in mice (19-21). These results, together with 
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evidence of the effect of antibiotic treatment on the intestinal microbiota in humans, 
underscore the role of intestinal homeostasis in promoting the health of the host (5).  
 
Infections caused by Enterococcus species, initially considered to be only of 
endogenous origin, are often caused by certain genotypes that are highly adapted to the 
hospital setting (22). One of most common enterococcal infections is of the urinary tract 
(urinary tract infection, UTI) (7), which is often associated with the presence of catheters 
(catheter-associated urinary tract infection, CAUTI) (23). Enterococci are also common 
causes of intra-abdominal and pelvic infections, bacteremias and endocarditis (4), the 
later representing one of the most serious infections caused by Enterococcus, due to 
limited therapeutics options that have bactericidal activity against some of these bacteria 
(24).   
 
1.5. Insights into enterococcal pili and its association with virulence 
Adherence to host tissues is thought to be important in the pathogenesis of 
enterococcal infections such as UTIs and endocarditis (5, 25). The enterococcal genome 
encodes a number of factors, including members of the “microbial surface components 
recognizing adhesive matrix molecules” (MSCRAMM) family, that have been shown to 
play a role in adherence and to contribute to the pathogenesis of enterococci in 
experimental models of infections (5, 26). The enterococcal pili, like the pili of other 
Gram-positive organisms, are multimeric structures formed by LPxTG surface proteins 
that are part of the family of MSCRAMMs (26); these pili extend from the surface of the 
bacteria and are polymerized and anchored to the peptidoglycan cell wall by 
transpeptidase enzymes known as sortases (27, 28). 
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In E. faecalis, two pilus gene clusters (PGCs) have been described, the ebp (29) 
and the bee (biofilm enhancer in enterococci) loci (30). The ebp locus is considered part 
of the core genome of E. faecalis, as it was reported present in 99.8 % of E. faecalis 
isolates (31). The bee locus, in contrast, was carried by only 1.2 % of the isolates 
studied (31) and it was demonstrated to be encoded on a conjugative plasmid (30). The 
Ebp pili of E. faecalis have been extensively investigated; studies have shown the 
contribution of each pilus subunit, EbpA, EbpB and EbpC, to pilus structure (32, 33), and 
the role of Ebp and/or its subunits in adherence to components of the host extracellular 
matrix (ECM) (34, 35), adherence to human platelets (31), biofilm formation (29, 32) and 
in experimental animal models of UTI (32, 36), CAUTI (37) and endocarditis (29). The 
roles of the pilus specific sortase, Bps, and the housekeeping sortase, SrtA, in pilus 
biogenesis have also been established, with the former catalyzing pilin polymerization 
and the later anchoring the polymerized pilus to the cell wall (32). Furthermore, 
regulators of Ebp expression have been described (38, 39), as well as the role played by 
environmental signals in inducing pili production (29, 40). Chapter 2 of this dissertation 
elucidates an additional mechanism of Ebp regulation based on the presence of a rare 
initiation codon, ATT, as the translational start of the tip subunit of the pili, EbpA. 
 
On the other hand, E. faecium can encode up to four PGCs, called PGC-1 to PGC-
4, but the presence of these gene clusters is variable between E. faecium strains, as 
some of these clusters are present in plasmids that show predominance in isolates of 
clinical origin (41-44). In spite of the high relevance of E. faecium in the clinical setting, 
studies of E. faecium pili have been scarcer, with only two PGCs partially characterized, 
PGC-1 and PGC-3, the later also known as the empABC operon (previously, ebpABCfm) 
(43, 45-47). Only one study has addressed the role of one of these type of pili, the Emp, 
in an experimental model of infection (47). Chapter 3 of this dissertation serves to 
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provide further insight into the Emp pili; in particular, it contributes to the understanding 
of the role of each of the Emp subunits to pilus fiber structure, biofilm formation, 
adherence to ECM proteins and experimental infection.  
 
1.6. Defining the contribution of E. faecium clade types to GIT colonization and 
ampicillin resistance. 
The recent emergence of E. faecium in the healthcare setting is a reason of high 
concern for clinicians, as this species shows higher rates of antibiotic resistance, 
compared to E. faecalis, against antibiotics commonly used to treat enterococcal 
infections, including vancomycin and ampicillin (5, 7). Currently, the percentage of E. 
faecium isolates in US hospitals resistant to vancomycin is approximately 80% and an 
even higher percentage is resistant to ampicillin (5, 7, 48).  
 
Multi-locus sequence typing (MLST), a technique that interrogates the sequence of 
internal regions of multiple housekeeping genes, usually seven, has been widely used to 
study the population structure of E. faecalis and E. faecium (8, 49, 50). Whole genome 
sequence comparisons have provided further insight into the evolutionary trajectories of 
these two enterococcal species (51). In this next section, I will summarize the most 
important findings on the population biology and comparative genomics of E. faecium.  
 
Early population biology studies of E. faecium, using MLST and the eBURST 
algorithm, initially indicated that a certain lineage, named clonal complex 17 (CC17), was 
associated with the majority of hospital-acquired E. faecium infections and outbreaks 
(52). This clonal complex was characterized by high-level resistance to ampicillin, 
vancomycin and quinolones, and was also often associated with the presence of mobile 
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genetic elements such as IS16 (53) and putative virulence factors, including hylEfm 
(encoding a protein with homology to glycosyltransferases), espEfm (enterococcal 
surface protein), and MSCRAMMs (5, 54). The use of a more suitable algorithm to 
analyze the MLST data from species with high rates of recombination as E. faecium 
(53), and the use of genomic analyses, initially whole-genome microarray (55) and 
pyrosequencing (56), subsequently indicated that the isolates of the “CC17” were not 
strictly clonal, meaning that hospital-acquired E. faecium evolved from more than one 
founder (53). Nevertheless, these analyses confirmed the profound differences between 
the strains isolated from hospitals, causing infections and outbreaks, and the strains 
commonly found colonizing the GIT of healthy individuals in the community (56). 
 
More recent whole genome comparisons, by Galloway-Peña et al. and Palmer et 
al., found a deep evolutionary bifurcation between two E. faecium clades, the hospital-
associated (HA) clade or clade A and the community-associated (CA) clade or clade B 
(51, 57). The core gene sequences of these two clades differ by 3.5 to 10%, revealing 
that the differences between them are not only in the accessory genome, as was initially 
suggested, but also at the core genomic level (57, 58). Furthermore, pairwise 
comparisons that quantitated the relationship of strains in the two clades spanned from 
93.9 to 95.6% average nucleotide identity (ANI), which overlaps with the percentage that 
delineates a different species (51). In addition, molecular clock calculations indicated 
that this bifurcation occurred long before the antibiotic era, indicating that the emergence 
of E. faecium in the hospital setting is not a consequence of a recent evolution of a 
lineage from the commensal clade (57).  
 
In 2013, Lebreton et al. sequenced and analyzed the genome of 51 strains that 
belong to different sequence types (STs) and were isolated from diverse sources at 
  
9 
different time points, and compared these strains along with the 22 previous analyzed 
genomes that at the time were publicly available in NCBI (59). The results of this 
analysis confirmed the previously described ancient phylogenetic split between the 
clades but, more importantly, it provided evidence of a more recent bifurcation within the 
clade A into subclade A1 (associated with infections in the hospital) and subclade A2 
(associated primarily with animals but also reported in human infections) (59). It was 
estimated that this later split occurred around the time antibiotic use was instituted in 
clinical settings and animal agriculture practices (59).  
 
Among many differences, strains of the E. faecium clades differ in genome size, 
with larger overall as well a core genomes found in subclade A1 strains compared to 
clade B and subclade A2 strains; however, subclade A2 strains have larger pan-
genomes (59). Enrichment of mobile genetic elements including plasmids, prophages, 
genomic islands and insertion sequences was observed in subclade A1 strains (59). 
Furthermore, antibiotic resistance genes were more frequently found in clade A strains 
than in clade B strains, with some resistance determinants, including the vanA and vanB 
genes that confer resistance to vancomycin, completely absent from clade B strains 
(59). Clade A strains were also characterized by higher recombination and mutation 
rates compared to clade B strains (59, 60). In addition, differential presence of genes 
and gene clusters with predicted functions in carbohydrate metabolism was observed 
between the E. faecium clades (59). It has been suggested that the ability to utilize 
different carbohydrates by the E. faecium clades is one of the main driving forces for the 
divergent evolution of the clades (3, 59). Although these studies have established 
substantial sequence divergence in the core genome and differences in the gene 
content between the E. faecium clades, the determinants that favor clade B 
predominance in the GIT of healthy individuals but subclade A1 prevalence in individuals 
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in the healthcare setting are far from being understood (53, 55, 56, 59). In Chapter 4, 
using a murine model of GIT colonization, differences in colonization dynamics by the 
distinct E. faecium clades are investigated. 
 
As described above, there are extensive differences between the E. faecium clades; 
one important core-intrinsic difference of prominent clinical relevance is the pbp5 gene, 
which encodes a high molecular weight class B PBP, PBP5 (57, 58). PBPs are part of 
the penicilloyl serine transferase family of enzymes, which are involved in the final 
stages of peptidoglycan synthesis (61); these reactions include transglycosylation and 
transpeptidation (62). The genome of E. faecium encodes six different high molecular 
weight PBPs, three genes (ponA, pbpF and pbpZ) encoding class A PBPs, which are 
multifunctional enzymes with a glycosyltransferase (GTase) domain and a 
transpeptidase (TPase) domain and three genes (pbp5, pbpA and pbpB) encoding 
mono-functional class B TPases (63). ȕ-lactam antibiotics exhibit structural analogy with 
the D-Ala-D-Ala carboxy terminus of the peptidoglycan pentapeptide; thus, these drugs 
irreversibly inactivate PBPs by forming an ester bond with the active site serine of the 
enzyme (64). 
 
PBP5 is considered the main determinant of ampicillin resistance in E. faecium (65), 
which is attributed to its intrinsic low affinity for ȕ-lactam antibiotics (66, 67). In Chapter 
5, we further our previously published findings on the role that the different pbp5 variants 
play in ampicillin resistance (58, 68) and evaluate the contribution of the E. faecium 
clade backgrounds to differential PBP5 protein levels.  
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CHAPTER 2. ATTenuation Starts with ATT. 
 
This chapter is based upon work published in the journal mBio entitled “The 
Enterococcus faecalis EbpA Pilus Protein: Attenuation of Expression, Biofilm Formation, 
and Adherence to Fibrinogen Start with the Rare Initiation Codon ATT. mBio. 2015: 6: 
e00467-15. I am the first author of this publication (Montealegre MC, La Rosa SL, Roh 
JH, Harvey BR, Murray BE) and I was responsible for preparing the original manuscript 
and conducted the majority of experiments described. Copyright of all material published 
in mBio remains with the authors.  
For additional information about ASM’s permission policies associated with commercial 
reuse of mBio content, see http://mbio.asm.org/site/misc/reprints.xhtml 
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2.1. INTRODUCTION 
Ebp are considered important contributors to the pathogenicity of E. faecalis (29, 
32, 36, 37). Our lab have previously shown that Ebp are important for adherence of E. 
faecalis OG1RF to host ECM proteins, including fibrinogen and collagen, a process that 
is considered crucial in the initial steps of infection (34, 35). Furthermore, it was 
demonstrated that Ebp pili play a role in biofilm formation (29, 32) and in experimental 
animal models of endocarditis (29) and ascending UTIs (36). The role of Ebp has also 
been established in a model of CAUTI (37). The ebp locus consists of an operon of three 
genes, ebpA, ebpB and ebpC, that encode the pilus subunits, or pilins, and bps, 
encoding a class C sortase (29, 32). The three pilin genes and the downstream sortase 
are co-transcribed, but a second promoter controls the independent expression of bps 
(32). Regulation of pilus expression has been shown to occur through the action of two 
positive regulators, EbpR and rnjB (38, 39) while the fsr system was shown to be a weak 
repressor (40). Furthermore, environmental conditions, including bicarbonate (40) and 
the presence of serum (29), positively affect Ebp pilus production.  
 
 Several reports have shown that EbpC forms the backbone polymer, while EbpA 
and EbpB are present at the tip and at the base of the pilus fiber, respectively (29, 32, 
33, 37). In addition, our electron microscopy studies indicated that the majority of the 
EbpA protein is found on the surface of E. faecalis OG1RF cells (32) and analyses of the 
contribution of each structural subunit of the Ebp pili revealed the importance of EbpA to 
pilus biogenesis (32, 33, 37). We previously reported that deletion of ebpA resulted in 
the formation of fewer but extremely long pili compared to wild-type OG1RF, which 
suggested a role for EbpA in the initiation as well as termination of pilus polymerization 
(32). We corroborated the role of EbpA as a factor that influences the length of pili by 
controlled overexpression of EbpA from a nisin-inducible promoter in a ΔebpA mutant, 
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which led to a gradual decrease in pilus length as the concentration of nisin was 
increased (32). Deletion of ebpA also affected the overall levels of the other Ebp pilin 
subunits, without altering the transcript levels of the downstream genes (32). EbpA has 
been demonstrated to play a crucial role in biofilm formation and in a model of UTI, with 
the ebpA deletion mutant attenuated approximately to the same level as observed with 
the ebpABC operon deletion (32). In addition, Nielsen et al. showed the contribution of 
EbpA in the colonization of bladders and intrabladder implants in CAUTIs, and revealed 
that the metal ion-dependent adhesion site (MIDAS) motif present in EbpA’s von 
Willebrand factor A (VWA) domain is important for pilus function (37). More recently, this 
group demonstrated that immunization with EbpA inhibits binding of E. faecalis to 
fibrinogen and provides protection in catheter-associated bladder infection in mice (69). 
Additionally, we showed that a monoclonal antibody targeting the shaft of the pili, EbpC, 
prevents endocarditis in rats (70). 
 
 We previously predicted that the most likely translational start codon of EbpA in 
E. faecalis OG1RF is the very rarely used triplet ATT (AUU in the corresponding mRNA), 
which is located 9 bp downstream of a suitable ribosomal binding site (RBS) and 120 bp 
upstream of the current genome database annotation of an ATG start codon (Figure 2.1) 
(29). In the majority of mRNAs, translation initiates from the codon AUG that in 
prokaryotes codes for formylmethionine; nevertheless, other NUG codons are 
occasionally found as translational starts (71, 72).   
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Figure 2.1. Schematic representation of the ebpABC-bps operon of E. faecalis 
OG1RF. 
The locus consists of three genes ebpA, ebpB and ebpC, encoding the pilin subunits, 
and bps encoding a class C sortase. The putative promoter region (with the -35 and -10 
promoter boxes), the predicted transcriptional start (+1), the predicted ribosome-binding 
site (RBS), the ATT postulated start codon and the ATG annotated start codon are 
shown. The position of the two successive stop codons introduced to generate strain 
TX5751 is also denoted. 
  
AAGCTGGTGTGATTTAATGAGCTCCTTCTCTGTATAATAATTATCAGATTAGAATAATGAAATTTTACGTGCTAGGCAATTCTA
ATTTAACTGTTAATTCATAAAAGAAAGGAGAGAACAGACATTAAATTACTAAAGAAATTTGGGGTTTTCGGCGTAGTCTTTTTA
CTTGTCTCATCCTATTTCATACCGCTCATTGGCTATGCAGAAACAGCCAAAGAAGTTGAAATTACATCCGCTCAAATGATAACA  
-35                                                 -10                    +1
RBS
ebpA ebpC bpsebpB
STOP
TAGTAA
  
15 
 In only very few instances has the AUU codon been reported as the translational 
start for protein synthesis in bacteria (73, 74). The rarity of AUU as a start codon is 
attributed to the fact that the initiation factor 3 (IF3) discriminates against non-canonical 
start codons (72). As observed in other prokaryotic species, in E. faecalis OG1RF, the 
use of AUU as the initiation of protein synthesis is very rare, and there is no evidence 
indicating that other E. faecalis proteins, besides EbpA, start translation with this codon. 
In addition, when our search of other several sequenced E. faecalis strains found 
conservation of this codon, we postulated that this codon participates in regulation of 
EbpA expression. To test this hypothesis and our prediction of AUU as the start codon of 
EbpA protein synthesis, we first used site-directed mutagenesis to introduce, in E. 
faecalis OG1RF, two successive stop codons between the ATT predicted initiation 
codon and the currently annotated ATG start codon, to experimentally show that the ATT 
indeed determines the start of EbpA protein synthesis. Then, we constructed a derivative 
of OG1RF in which the ATT codon of ebpA was replaced with ATG, and investigated the 
effect of this change on translation, EbpA and EbpC surface display, biofilm formation 
and adherence to fibrinogen.  
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2.2. MATERIALS AND METHODS 
Bacterial strains, plasmids, and routine growth conditions 
Bacterial strains and plasmids used in this chapter and their relevant characteristics 
are listed in Table 2-1. E. faecalis strains were routinely grown at 37°C using brain heart 
infusion (BHI) (Becton, Dickinson (BD), Franklin Lakes, NJ) broth or agar. Tryptic soy 
broth (BD) supplemented with 0.25% glucose v/v (TSB-G) and BHI broth supplemented 
with 40% horse serum (Sigma-Aldrich, Saint Louis, MO) v/v (BHI-S) were used for some 
experiments. Escherichia coli strains used for cloning experiments were grown at 37°C 
Luria-Bertani (LB) (BD) broth or agar. Growth characteristics of OG1RF and its 
derivatives were assessed in BHI broth based on the optical density at 600 nm (OD600). 
In addition, samples were taken at 0, 3, 6, 8 and 24 hours for CFU determination on BHI 
agar, as previously described (47). 
Construction of mutants 
Specific point mutations were generated by modifying a previously described 
methodology (75), based on the pHOU1 vector (76) that carries the pheS* allele that 
confers susceptibility to p-chloro-phenylalanine (p-Cl-Phe). Strains TX5751 and TX5731 
were constructed using E. faecalis OG1RF as the parental strain, while a revertant 
strain, named TX5732, was generated by placing back the ebpAATT start codon into the 
TX5731 strain background (Table 2-1). In brief, two external primers ebpA-Ext-F-BamHI 
and ebpA-Ext-R-PstI containing the BamHI and PstI restriction sites, respectively, and 
two internal complementary primers containing the desired change were designed 
(Table 2-2).   
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Table 2-1. Bacterial strains and plasmids used in chapter 2 
AMP, ampicillin; ERY, erythromycin: FUS, fusidic acid; GEN, gentamicin; RIF, rifampicin. 
Superscript “R” designates resistance.   
Strain or 
Plasmid Relevant Characteristic(s) Reference 
Strains   
E. faecalis   
OG1RF Laboratory strain; RIFR, FUSR (77) 
TX5751 OG1RF with two point mutations at nucleotides 13 and 
16 after the putative ebpA ATT initiation codon that 
changed two lysine residues (AAG and AAA) to two 
stop codons (TAG and TAA, respectively) (ebpASTOP). 
This study 
TX5731 OG1RF with a point mutation that changed the ebpA 
putative ATT start codon ATT to ATG (ebpAATG). 
This study 
TX5732 Restored OG1RF ebpAATT. The mutated ebpAATG 
codon was restored to wild-type ebpAATT. 
This study 
TX5608 OG1RFebpABC; ebpABC operon deletion mutant (39) 
TX5620 OG1RFebpA; ebpA deletion mutant (32) 
E. coli   
TG1 E coli host strain used for routine cloning  
EC1000 E coli host strain for cloning of RepA-dependent 
plasmids 
(78) 
Plasmids   
pGEM-T Easy Plasmid used for initial cloning of PCR fragments; 
AMPR. 
Promega 
pHOU1 Conjugative donor plasmid used for the introduction of 
point mutations into E. faecalis; confers GENR and 
carries the counterselectable pheS* gene. 
(76) 
pSD2 Plasmid used to construct the translational lacZ 
fusions. The lacZ gene lacks a promoter, a RBS and a 
start codon; confers AMPR and ERYR. 
(79) 
pTEX5749 
 
pSD2 plasmid containing a fragment from -261 bp 
upstream to 31 bp downstream of the ATT start codon 
of the ebpA gene of E. faecalis  OG1RF (pSD2-
ebpAATT::lacZ). 
This study 
pTEX5750 pSD2 plasmid containing a fragment from -261 bp 
upstream to 31 bp downstream of the mutated ATG 
start codon of the ebpA gene of E. faecalis TX5731 
(pSD2-ebpAATG::lacZ). 
This study 
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Table 2-2. Oligonucleotides used in chapter 2 
 
  
Primer Name Sequence 5- 3 Relevant Characteristics 
Mutant Construction 
ebpA-Ext-F-
BamHI 
CGGGATCCTCGTTGAC
GTTTTTGCCATA 
External forward; BamHI site underlined. 
ebpA-Ext-R-PstI TTCTGCAGTGGGCACC
ACCATCTTTATT 
External reverse; PstI site underlined. 
ebpA-Stop-F ATTAAATTCTATAGTAA 
TTTGGGGTTTTC 
Internal forward; this primer creates two point 
mutations (underlined) that change two lysine 
residues (AAG and AAA) to two stop codons 
(TAG and TAA, respectively). 
ebpA-Stop-R GAAAACCCCAAATTA 
CTATAGTAATTTAAT 
 
Internal reverse; this primer creates two point 
mutations (underlined) that change two lysine 
residues (AAG and AAA) to two stop codons 
(TAG and TAA, respectively). 
ebpA-Ini-ATG-F GGAGAGAACAGACATG
AAATTACTAAAGAAA 
Internal forward; this primer creates a point 
mutation (underlined) that changes EbpA ATT 
predicted start codon of OG1RF to ATG. 
ebpA-Ini-ATG-R TTTCTTTAGTAATTTCA
TGTCTGTTCTCTCC 
Internal reverse; this primer creates a point 
mutation (underlined) that changes EbpA ATT 
predicted start codon of OG1RF to ATG. 
ebpA-Ini-ATT-F GGAGAGAACAGACATT
AAATTACTAAAGAAA 
Internal forward; this primer creates a point 
mutation (underlined) that reverts the ATG 
mutated start codon of TX5731 back to ATT. 
ebpA-Ini-ATT-R TTTCTTTAGTAATTTAA
TGTCTGTTCTCTCC 
Internal reverse; this primer creates a point 
mutation (underlined) that reverts the ATG 
mutated start codon of TX5731 back to ATT. 
β-gal fusions 
ebpA-Fus-F-SalI GCGCGCGTCGACGAC
ACGAATGATTTCTTCC
A 
Forward for the construction of lacZ fusions in 
the pSD2 vector; SalI site underlined. 
ebpA-Fus-R-
BamHI 
GCGCGCGGATCCCGA
AAACCCCAAATTTCTTT
AG 
Reverse for the construction of lacZ fusions in 
the pSD2 vector; BamHI site underlined. 
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First, two independent PCR reactions using the respective external and internal 
primers were carried out. Then, the two PCR amplicons were joined together by a cross-
over PCR and the generated fragments, now containing the desired mutations 
(confirmed by sequencing), were cloned into the pGEM vector and then subcloned into 
pHOU1 (76) using the BamHI and PstI sites. The recombinant pHOU1 plasmids were 
propagated in E. coli EC1000 and then electroporated into E. faecalis CK111 (Table 2-1) 
(75). Subsequently, the recombinant pHOU1 plasmids were transferred into E. faecalis 
OG1RF (or TX5731) by filter mating with CK111, followed by culturing the gentamicin-
resistant colonies that integrated the plasmid on MM9-yeast extract glucose (MM9YEG) 
medium supplemented with 10 mM p-Cl-Phe as described in (75, 76), to select for the 
colonies from which the plasmid had excised. Sequencing and pulsed field gel 
electrophoresis (PFGE) were performed to detect the mutations in the correct 
background.  
Construction of translational lacZ fusion vectors and β-galactosidase assay 
The region extending from 261 bp upstream to 31 bp downstream of the postulated 
ebpA ATT translational start codon was PCR amplified from E. faecalis OG1RF and its 
ebpAATG mutant, TX5731, digested with SalI and BamHI and cloned into the pSD2 vector 
(Table 2-1) (79). The reporter gene of pSD2, lacZ, lacks a promoter, a RBS and a start 
codon. Constructs, harboring either the native (pTEX5749) or the mutated (pTEX5750) 
form of the ebpA start codon, were propagated in E. coli TG1 before electroporation into 
E. faecalis OG1RF, TX57γ1 and TX57γβ. ȕ-galactosidase activity was assayed in TSB-
G or BHI-S, as previously described (80).  
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Flow cytometry 
Flow cytometry analysis of E. faecalis strains was performed as previously 
described (39) with minor modifications. Cells grown in TSB-G to mid-logarithmic phase 
were collected by centrifugation and washed twice with 2% bovine serum albumin (BSA) 
in PBS. The bacterial cells were resuspended in 100 μl of the previously described 
affinity-purified polyclonal antibodies against EbpA (29) (1μg/ml), and incubated for 30 
min at room temperature (RT). After a washing step, secondary labeling was performed 
with 1:100 of phycoerythrin-conjugated goat anti-rabbit IgG for 30 min, and cells were 
washed and fixed with 1% of paraformaldehyde for analysis using a BD FACS Calibur 
flow cytometer (BD Biosciences, San Jose, CA).  
Whole-cell ELISA (WC ELISA)  
EbpA and EbpC surface display by OG1RF and the panel of mutants was evaluated 
as previously described, with minor modifications (32). Briefly, bacteria grown overnight 
in TSB-G were diluted in the same medium to an OD600 of 0.1 and incubated until they 
reached mid-logarithmic phase. Cells were collected by centrifugation and washed twice 
with PBS before they were resuspended in 50 mM carbonate-bicarbonate buffer, pH 9.6, 
to an OD600 of 1.0. Immulon 1B plate wells (Thermo Fisher Scientific, Waltham, MA) 
were coated for 1 h with E. faecalis cells, followed by two washes with PBS containing 
0.05% Tween 20 (PBS-T). The wells were then blocked for 1 h with 2% bovine serum 
albumin (BSA), followed by a 1 h incubation with affinity-purified polyclonal antibodies 
against EbpA and EbpC, respectively (1:5,000 dilution of 1 mg/ml) (29). After three 
washes with PBS-T to remove the unbound antibodies, goat anti-rabbit F(ab′)2 fragment 
conjugated to alkaline phosphatase (AP) (Jackson ImmunoResearch Laboratories, West 
Grove, PA) (1:5,000 dilution) was added and incubated for 1 h. Next, the wells were 
washed twice with PBS-T and once with PBS, followed by the addition of AP substrate 
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solution. The absorbance at 405 nm was measured with a microplate reader (Thermo 
Fisher Scientific). 
Biofilm formation assay 
Biofilm density was measured as previously described (81), with some 
modifications. In brief, E. faecalis strains from overnight cultures in TSB-G broth were 
diluted in the same medium to an OD600 of 0.1 and grown statically for 3 h or 24 h at 
37°C in 96-well polystyrene plates (BD). The plates were gently washed with PBS, and 
then the cells were fixed with Bouin’s solution (Sigma-Aldrich) for 30 min. After two 
washes with PBS, bacterial cells were stained with a 1% crystal violet solution (Sigma-
Aldrich) for 30 min. Excess crystal violet was removed by rinsing thoroughly with distilled 
water followed by the addition of ethanol-acetone (80:20) to solubilize the dye and 
dissolve the biofilms. The absorbance at 570 nm was measured with a microplate reader 
(Thermo Fisher Scientific). Two independent experiments were performed in duplicate (8 
wells per strain each in duplicate). 
Fibrinogen binding assay 
E. faecalis adherence to immobilized fibrinogen was assayed using the CytoSelect 
cell adhesion assay kit (Cell Biolabs, San Diego, CA). First, E. faecalis OG1RF and its 
derivatives from overnight cultures grown at 37°C in BHI-S were normalized to an OD600 
of 0.05 and cultured to mid-log phase. Bacterial cells were collected by centrifugation, 
washed three times with PBS, and resuspended in 0.5% BSA to an OD600 of 1.0. A 
volume of 150 μl of the cell suspension was added to the fibrinogen-precoated wells and 
incubated for 1 h at 37°C. The unbound bacteria were removed by gently washing each 
well two times with PBS. Next, 200 μl of the cell stain solution was added to each well 
and incubated for 10 min at RT, followed by two washes with deionized water. After air-
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drying the wells, 200 μl of extraction solution was added per well. The plate was 
incubated for 10 min on a shaker, and then 150 μl from each extracted sample was 
transferred to a 96-well microtiter plate (BD). The absorbance at 570 nm was measured 
with a microplate reader (Thermo Fisher Scientific). 
Statistical analyses 
Analysis of variance (ANOVA) with Bonferroni’s multiple comparison post-test was 
used to compare the results. GraphPad Prism version 4.00 (GraphPad Software, San 
Diego, CA) was used for the statistical analyses. 
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2.3. RESULTS  
Introduction of stop codons indicate that ATT (AUU) is the start codon of EbpA 
protein synthesis 
The ebpA gene is the first gene of the ebpABC operon that encodes the E. faecalis 
Ebp pili (Figure 2.1). The current genome annotation of the E. faecalis strain V583 
indicates that EbpA is an 1103-residue protein with a VWA domain; however, closer 
examination of the operon sequence revealed that no recognizable RBS is present 
upstream of the ebpA annotated start codon, ATG (29). In addition, no recognizable 
signal peptide or cleavage site was found downstream of the ATG annotated as the start 
codon of the predicted 1103-residue EbpA protein (EbpA-1103) (Figure 2.2-A). We 
predicted that the most likely, but very unusual, start codon of ebpA is the triplet ATT, 
located 9 bp downstream of a recognizable RBS and 120 bp upstream of the currently 
annotated ATG start codon (Figure 2.1). Using the SignalP 4.1 server 
(http://www.cbs.dtu.dk/services/SignalP/), we found a potential cleavage site at position 
30 after the ATT codon (EbpA-1143) (Figure 2.2-B). In addition, the other two proteins 
encoded by the ebpABC operon, EbpB and EbpC, have well-defined signal sequences 
as well as cleavage sites (Figure 2.2-C-D). Furthermore, protein alignments of EbpA-
1103 and EbpA-1143 with EmpA (EbpA homolog in E. faecium) supports the ATT start 
for EbpA protein synthesis (data not shown). To experimentally confirm that the 
designated ATG (located 120 bp downstream of our predicted ATT start) is not the start 
codon for EbpA protein synthesis, we used site-directed oligonucleotide mutagenesis to 
generate the strain TX5751 in which two lysine residues, AAG and AAA at positions five 
and six after the ATT, respectively, were changed to two stop codons, TAG (amber) and 
TAA (ocher) (Figure 2.1 & Table 2-1).  
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Figure 2.2. Prediction of signal peptides and cleavage sites of the proteins 
encoded by the ebpABC operon. 
The presence and location of signal peptides and cleavage sites were predicted using 
the SignalP 4.1 server from the amino acid sequence of the annotated 1103-residue 
EbpA protein (EbpA-1103) (A), the 1143-residue EbpA protein (EbpA-1143) (B), EbpB 
(C) and EbpC (D). The C-score (raw cleavage site score), S-score (signal peptide score) 
and Y-score (combined cleavage site score) are shown for each sequence. In addition, 
the average S-score (mean S) of the possible signal peptide (from position 1 to the 
position immediately before the maximal Y-score (combined cleavage site score)) and 
the D-score (discrimination score), used to discriminate signal peptides from not signal 
peptides, are indicated. The D-cutoff value used was 0.4. 
 
A. EbpA-1103                                                                                    B. EbpA-1143
C. EbpB                                                                                          D. EbpC
mean S=0.648
D=0.715 
mean S=0.488
D=0.389
mean S=0.096
D=0.107
mean S=0.788
D=0.692
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Our rationale was that, if translation starts from ATT, the introduction of a stop 
codon would signal termination of translation and no EbpA protein would be produced; 
for this purpose, we introduced two stop codons in order to avoid read through, as was 
reported when only one stop codon was inserted at the 5’ end of a chromosomal copy of 
a gfp reporter gene in Bacillus subtilis (82). In contrast, if the currently annotated ATG is 
the start of EbpA synthesis, the introduction of the stop codons before this ATG would 
not affect EbpA translation. As we predicted, flow cytometry showed that E. faecalis 
OG1RF displayed a strong EbpA signal (Figure 2.3-A), while strain TX5751 was 
negative for EbpA surface display (Figure 2.3-B). Next, we investigated the conservation 
of this unusual codon as the start of EbpA protein synthesis and found 100% 
conservation of the ATT codon in the 347 E. faecalis strains with available genome 
sequences in NCBI (data not shown). In addition, we interrogated the genome 
annotation for EbpA homologs in other enterococcal species including E. faecium, 
Enterococcus hirae, Enterococcus casseliflavus, Enterococcus mundtti and 
Enterococcus gallinarum and found that in all but E. gallinarum, ATG was annotated as 
start codon of these EbpA homologs (Figure 2.4). Furthermore, a recognizable RBS was 
present appropriately upstream of these ebpA-like genes’ ATG annotated start codons. 
Interestingly, no recognizable RBS was observed upstream of the annotated ebpA ATC 
start codon in E. gallinarum (Figure 2.4), raising the possibility of an alternative start for 
EbpA protein synthesis in this enterococcal species.  
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Figure 2.3. Flow cytometry analysis of EbpA surface display by wild-type E. 
faecalis OG1RF and TX5751.  
Flow cytometry profile of (A) E. faecalis OG1RF (ebpAATT) and (B) TX5751 (ebpASTOP), 
each grown in TSB-G to exponential phase and labeled with anti-rEbpA antibody. The 
mean fluorescence intensity (MFI) is indicated.  
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Figure 2.4. DNA sequence alignment of 18 nucleotides upstream of the annotated 
initiation codon of E. faecalis ebpA and its homologs in five enterococcal species.  
The annotated start codons and predicted RBSs are indicated for E. faecalis ebpA and 
its homologs in E. faecium (TX16), E. hirae (ATCC 9790), E. casseliflavus (EC20), E. 
mundtti (QU25) and E. gallinarum (A6981). 
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The start codon ATT affects EbpA surface display 
The use of a rare start codon as the translational start of EbpA, along with its 
conservation in all published E. faecalis genomes, led us to the hypothesis that this 
codon may play a role in the regulation of Ebp pilus expression. To investigate this, we 
constructed a single nucleotide variant, named TX5731 in which the ebpA ATT triplet of 
E. faecalis OG1RF was replaced with ATG (ebpAATG), and then explored the effect of 
this initiation codon change on the levels of EbpA surface display. WC ELISA using anti-
rEbpA, performed after growing the cells to exponential phase in TSB-G medium, 
revealed that strain TX5731 carrying ATG as the initiation codon of ebpA had 
significantly increased amounts of EbpA on the surface compared to OG1RF (p < 0.001; 
Figure 2.5). To confirm that the differences observed between the parental strain, 
OG1RF, and its ebpAATG mutant (TX5731) were due to the mutation in the ebpA start 
codon, we generated a revertant strain (TX5732), by replacing the ATG of TX5731 with 
the original ebpA start codon ATT (ebpAATT), in the native location. TX5732 displayed 
similar EbpA levels on the surface to that observed on OG1RF, demonstrating the role of 
the initiation codon in the regulation of EbpA protein levels (Figure 2.5). In addition, WC 
ELISA did not show any EbpA on the surface of the strain carrying the two consecutive 
stop codons after the ATT initiation codon, TX5751, nor on the ebpA deletion mutant, 
TX5620 (Figure 2.5). EbpC surface display was also investigated under the same growth 
conditions and the results revealed a small but non-significant increase in EbpC on the 
surface of TX5731 compared to OG1RF and TX5732 (Figure 2.6). As expected, no 
surface display of either EbpA or EbpC was observed on the surface of TX5608, the 
ebpABC operon deletion mutant (Figure 2.5 & Figure 2.6). Similarly, when the cells were 
grown in BHI-S the ebpAATG mutant, TX5731, also showed a significant increase surface 
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Figure 2.5. Effect of the ebpA initiation codon on EbpA surface display measured 
by WC ELISA. 
EbpA surface display was detected using anti-rEbpA. Bars represent the means of 
absorbance measured at 405 nm ± standard deviations from two independent 
experiments representing six wells per strain. The mean absorbance values were 
compared using ANOVA with Bonferroni’s post-test (***, p ≤ 0.001; ns, p > 0.05). 
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Figure 2.6. EbpC surface display measured by WC ELISA.  
EbpC surface display was detected using affinity-purified polyclonal antibodies against 
EbpC. Bars represent the means of absorbance measured at 405 nm ± standard 
deviations from two independent experiments representing six wells per strain. The 
mean absorbance values were compared using ANOVA with Bonferroni’s post-test (ns, 
p > 0.05). 
  
  
31 
display of EbpA compared to the ebpAATT counterparts, OG1RF and TX5732 (p < 0.001; 
data not shown). Quantitation of surface-localized EbpA protein was also performed by 
flow cytometry. The mutant strain TX5731, with ATG, showed increased levels of EbpA 
on the cell surface, compared to OG1RF and TX5732, corroborating the results obtained 
with whole-cell ELISA (data not shown). 
β-galactosidase production is reduced by the presence of ATT as the start codon 
of an ebpA-lacZ fusion  
To explore the direct contribution of the EbpA initiation codon to translational 
efficiency, two translational reporter fusions, pTEX5749 and pTEX5750, were generated 
by amplifying an 292 bp fragment from -261, including the promoter region of ebpA, to 
31 bp downstream of the translational start codon from E. faecalis OG1RF and TX5731, 
respectively (Figure 2.7). These fragments were fused to the reporter gene lacZ (Figure 
2.7), and after electroporation of the fusion constructs into E. faecalis OG1RF, TX5731 
and TX57γβ, ȕ-galactosidase activity was assayed following growth in TSB-G (Figure 
2.8) and BHI-S (Figure 2.9). Under both growth conditions and in each of the strain 
backgrounds, ȕ-galactosidase activity from cells carrying the reporter fusion pTEX5750 
with ATG as the start codon was significantly greater compared to cells carrying the 
reporter fusion pTEX5749 with the triplet ATT as the initiation codon of translation (p < 
0.001) (Figure 2.8 & Figure 2.9). It is interesting to note that strain TX5731 carrying 
either pTEX5749 or pTEX5750 expressed significantly higher levels of the reporter 
protein compared to OG1RF and TX5732 carrying the corresponding reporter fusions (p 
< 0.001), which could suggest a positive-feedback loop controlling EbpA expression.  
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Figure 2.7. ebpA::lacZ tranlational fusions. 
Schematic representation of the ebpA::lacZ fusions pTEX5749 (pSD2-ebpAATT::lacZ)  
and pTEX5750 (pSD2-ebpAATG::lacZ) carrying ATT and ATG as the start of EbpA::LacZ 
fusion protein synthesis, respectively. 
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Figure 2.8. Beta-galactosidase expression from ebpA::lacZ tranlational fusions in 
TSB-G. 
ȕ-galactosidase activity in E. faecalis OG1RF and its ebpA start codon derivatives, 
TX5731 and TX5732 containing either pTEX5749 (gray bars) or pTEX5750 (black bars) 
after grown to mid-log phase in TSB-G. Bars represent the means ± standard deviations 
of four independent assays each with 2 duplicates. The mean values were compared 
using ANOVA with Bonferroni’s post-test (***, p≤0.001; ns, p > 0.05). Dr. Sabina Leanti 
La Rosa contributed to the β-galactosidase assay. 
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Figure 2.9. Beta-galactosidase expression from ebpA::lacZ translational fusions in 
BHI-S. 
ȕ-galactosidase activity in E. faecalis OG1RF and its ebpA start codon derivatives, 
TX5731 and TX5732 containing either pTEX5749 (gray bars) or pTEX5750 (black bars) 
after grown to mid-log phase in BHI-S. Bars represent the means ± standard deviations 
of four independent assays each with 2 duplicates. The mean values were compared 
using ANOVA with Bonferroni’s post-test (***, p≤0.001; ns, p > 0.05). Dr. Sabina Leanti 
La Rosa contributed to the β-galactosidase assay.  
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In contrast, no differences in ȕ-galactosidase activity were observed between 
OG1RF and TX5732 (Figure 2.8 & Figure 2.9). In addition, we observed that in BHI-S, ȕ-
galactosidase activity was increased approximately 3-fold compared to TSB-G grown 
cells in both the ATT (pTEX5749) and ATG (pTEX5750) constructs, but the relationship 
of ȕ-galactosidase from the ATT and the ATG start codon was still maintained (Figure 
2.8 & Figure 2.9). Importantly, the differences in ȕ-galactosidase activity are not a 
consequence of differences in growth rate, as OG1RF and its derivatives carrying the 
two plasmids, pTEX5749 and pTEX5750, exhibited equivalent growth kinetics (data not 
shown).  
ATT as the initiation codon of ebpA translation correlates with less biofilm 
formation 
Previous studies showed that deletion of ebpA had a marked effect on the ability of 
E. faecalis OG1RF to form biofilm (32). We therefore investigated the impact of the ebpA 
initiation codon on early biofilm development (3 hours) and on mature biofilm (24 hours). 
When we scored biofilm after 3 hours of static incubation, the strain carrying ATG as the 
initiation codon of EbpA, TX5731, showed a significant increase in biofilm density 
compared to the strains carrying ATT, OG1RF and the revertant TX5732 (median for 
TX5731, 0.68 versus 0.58 and 0.57 for OG1RF and for TX5732, respectively; p < 0.001) 
(Figure 2.10-A). A smaller but still significant increase was observed in biofilm density 
after 24 hours of static incubation the ebpAATG mutant, TX5731, compared to OG1RF 
and TX5732 (p < 0.001; Figure 2.10-B). Consistent with previous findings (29, 32, 38, 
39), a marked reduction in biofilm formation was observed when the ebpABC operon 
(TX5608) or ebpA (TX5620) had been deleted (p < 0.001; Figure 2.10).  
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Figure 2.10. Effect of ebpA initiation codon on biofilm formation. 
Bacterial cells grown 3 h (A) or 24 h (B) in TSB-G were analyzed for biofilm formation 
using a crystal violet based assay. Bars represent the means of absorbance at 570 nm ± 
standard deviations from four independent assays (forty wells per strain). ANOVA with 
Bonferroni’s post-test was used to compare biofilm density values (***, p≤0.001; ns, p > 
0.05). 
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In addition, TX5751, the strain in which two successive stop codons were 
introduced after the ATT EbpA start codon showed reduction in biofilm density 
comparable to these two deletion mutants, corroborating the role played by EbpA in 
biofilm formation. The greater difference in biofilm density observed at the earlier time 
point compared to 24 hours between the strain carrying ATG as the start codon of EbpA 
(TX5731) versus the strains carrying ATT (OG1RF and TX5732) may be related to the 
data of Bourgogne and colleagues who demonstrated that ebpA expression peaked at 
log phase, followed by a decline during stationary phase (40). Hence, our results 
corroborate the importance of EbpA in biofilm production and demonstrate that the levels 
of EbpA protein on the surface of the cells are important for E. faecalis biofilm formation, 
in particular during its initial stages. 
ATT as the initiation codon of ebpA translation correlates with less binding to 
fibrinogen 
Nallapareddy et al. demonstrated that Ebp pilus-deficient mutants of E. faecalis 
OG1RF showed reduced binding to fibrinogen and to collagen type I (34); in addition, 
Flores-Mireles et al. confirmed that EbpA mediates attachment of E. faecalis to host 
fibrinogen (69). Therefore, we investigated the ability of OG1RF, its ebpAATG initiation 
codon mutant (TX5731) and the revertant strain ebpAATT (TX5732), to bind to fibrinogen. 
A slight but significant increase in binding to fibrinogen was observed when the initiation 
codon of ebpA was changed to ATG (TX5731) compared to OG1RF and TX5732 with 
the ATT initiation codon (p ≤ 0.05 and p ≤ 0.01, respectively; Figure 2.11). This result 
therefore indicates that the ATT initiation codon of EbpA also affects E. faecalis 
adherence to fibrinogen. 
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Figure 2.11. Effect of the ebpA initiation codon on the adherence of E. faecalis to 
immobilized fibrinogen. 
Bars represent means ± standard deviations of absorbance measured at 570 nm (for 4 
wells per strains). The mean values between E. faecalis OG1RF and its derivatives were 
analyzed using ANOVA with Bonferroni’s post-test (***, p ≤ 0.001; **, p ≤ 0.01; *, p ≤ 
0.05; ns, p > 0.05). 
  
  
39 
2.4. DISCUSSION 
In bacteria, the most frequently used translational start codon is AUG (90% of the E. 
coli mRNAs); however, alternative initiation codons including GUG (8%) and UUG (1%) 
are occasionally found (71, 72). In contrast, the triplet AUU has been reported in only 
two instances in E. coli, namely, the pcnB gene encoding poly(A) polymerase (PAPI) 
(73) and the infC gene encoding translation initiation factor IF3 (74). In both instances, 
expression of the corresponding proteins was limited by the presence of AUU as the 
translational initiation codon (73, 74, 83). We analyzed the genome of E. faecalis 
OG1RF and determined that in 81.5% of the open reading frames (ORFs), AUG is 
annotated to be the initiation codon, while in 10% and 8.5% of the instances, the codons 
GUG and UUG are predicted to initiate protein synthesis, respectively. However, we 
observed that the most likely translational start codon of EbpA in E. faecalis OG1RF is 
the rare triplet AUU (corresponding to ATT in the DNA) (Figure 2.1), while the E. faecalis 
infC gene, encoding IF3, is annotated to start with the canonical ATG. The presence of a 
rare start codon as the most likely start of EbpA protein synthesis and its conservation in 
all sequenced E. faecalis strains led us to the hypothesis that this codon plays a role in 
the translational regulation of EbpA expression. First, we experimentally confirmed that 
ATG is not the start of EbpA translation by introducing two successive stop codons in 
between the ATT we predicted is the initiation codon and the currently annotated ATG 
start codon of ebpA; as we expected, these stop codons abolished EbpA surface display 
(Figure 2.1 & Figure 2.3). Then, we constructed a derivative of OG1RF in which we 
replaced, in its native location, the ATT start codon of ebpA with ATG (TX5731) and then 
reverted this ATG to ATT (TX5732) and demonstrated that E. faecalis OG1RF and 
TX5732, carrying ATT as the start of EbpA protein synthesis, had reduced levels of 
EbpA on their surfaces compared to the strain TX5731, carrying ATG as the translational 
start (Figure 2.5). We previously demonstrated that EbpA levels influence the length and 
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number of pilus fibers, which led us to propose that EbpA is important for initiation as 
well as termination of pilus polymerization (32). Although it could be suggested that 
increased levels of EbpA protein observed on the surface of TX5731 carrying ATG as 
the initiation codon of ebpA (Figure 2.5) may result in a small increase in the number of 
pilus fibers but decreased pilus length, consistent with a small (albeit non-significant) 
increase in EbpC surface display (Figure 2.6), we postulate that the main effect of the 
ATT start codon is on EbpA levels exposed on E. faecalis cells, as the majority of EbpA 
appears as monomers on the cell surface (32). 
 
We inferred that the reduced levels of EbpA on the surface of E. faecalis OG1RF 
and TX5732 are a consequence of reduced rates of translation when ATT is present as 
the start of EbpA protein synthesis. Our results using translational reporter fusions to 
lacZ also indicate that, in E. faecalis, ATG is a more efficient start codon for the initiation 
of EbpA translation than ATT (Figure 2.8 & Figure 2.9), which is in accordance with the 
hierarchy of start codon efficiencies proposed in E. coli (84). Although other signals and 
factors play a role in the rate of translation initiation (84), including the Shine-Dalgarno 
(SD) sequence and the initiation factors IF1, IF2 and IF3 (85), evidence in E. coli 
indicates that, in the presence of an ATT start codon, IF3 increases the dissociation of 
the initiation complex, which includes the 30S ribosomal subunit, the specific initiator 
tRNA, the mRNA and the three initiation factors (72). It is interesting to note that ȕ-
galactosidase activity, which is a reflection of the levels of the EbpA-LacZ fusion protein 
inside the cell, was increased approximately 3.5 -folds when the reporter fusion start 
codon was ATG versus ATT (Figure 2.8), but a more discreet increase (approximately 
1.5 fold) was observed in EbpA surface display on TX5731 carrying ATG as the ebpA 
start codon versus the strains carrying ATT (OG1RF and TX5732) (Figure 2.5). One 
possibility that could explain this difference would be the existence of additional 
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regulatory mechanisms participating in the regulation of EbpA levels on the surface of 
the cells. In light of the current model of Ebp pilus assembly in E. faecalis (32, 33), one 
could infer that modulating the ratios of the major backbone subunit, EbpC, to the minor 
subunits, EbpA and EbpB, could be important for pilus biogenesis, since an individual 
pilus fiber is composed of multiple EbpC subunits while in theory only one EbpA and one 
EbpB subunits are required for the tip and base of one pilus fiber, respectively (32, 33). 
Therefore, it seems plausible that the ATT start codon of ebpA is a way to regulate the 
ratio of EbpA to EbpC in E. faecalis.  
 
Ebp pili are considered one of the major virulence factors of E. faecalis, playing a 
role in biofilm formation, adherence to fibrinogen and in the ability of E. faecalis to cause 
endocarditis and infection in mouse models of ascending UTI and CAUTI (29, 32-34, 36, 
37, 69). EbpA has been demonstrated to be the most important pilin in biofilm formation 
(32, 69), while deletion of ebpC, encoding the major pilin, had a minor effect (32) despite 
abrogating pilus formation; this suggests that EbpA, in monomeric or dimeric form, on 
the surface of E. faecalis cells is capable of sustaining biofilm formation even when it is 
not part of a pilus polymer (32, 33). In addition, it has been shown that the MIDAS motif 
present in EbpA’s VWA domain is crucial for EbpA-mediated biofilm formation and 
fibrinogen binding (70). Proteins containing VWA domains, which are widely distributed 
among the three domains of life, Eukaryota, Archaea and Eubacteria, often participate in 
cell adhesion and protein-protein interactions (86). Furthermore, other VWA-containing 
tip pilin proteins, including PilA of Streptococcus agalatiae and RrgA of Streptococcus 
pneumoniae, have also been implicated in binding to ECM proteins (87, 88). Considering 
the demonstrated role of EbpA in biofilm formation (32, 69) and fibrinogen adherence 
(69), we believed that identity of the EbpA start codon would impact these processes, 
which have been associated with the ability of E. faecalis to cause infection. Indeed we 
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found that the presence of ATT, compared to ATG, as the start codon of EbpA protein 
synthesis resulted in less biofilm formation (Figure 2.10) and decreased adherence to 
fibrinogen (Figure 2.11). Although the reasons behind the advantages or disadvantages 
of negatively regulating the levels of pilation are unknown, it has been suggested that 
high expression of pilin surface proteins could involve a fitness cost to the bacteria due 
to the selective pressure exerted by the immune system (89).  Indeed, Danne et al., 
demonstrated in Streptococcus gallolyticus that a mutant overexpressing pili showed 
reduced survival in human blood compared to a non-piliated mutant (89). In addition, 
they demonstrated that THP-1 human macrophages showed better opsonophagocytosis 
of highly-piliated bacterial cells than their non-piliated counterparts (89). Although we 
cannot discard the possibility that ATT as the start codon of EbpA protein synthesis has 
a role in E. faecalis human infections, the conservation of this rare codon in all 
sequenced E. faecalis strains implies that it appeared long before enterococci became 
common human colonizers and pathogens, and we speculate that its presence could 
have aided E. faecalis in some way in the environment or an early host, perhaps due the 
decrease adherence observed in weakly piliated cells, thus favoring dispersal. 
Regardless of why this change occurred, our results taken together, provide the first 
example of pilus regulation through the use of a very rare initiation codon and support 
our hypothesis that “ATTenuation starts with ATT”. 
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CHAPTER 3. Role of the Emp Pilus Subunits of Enterococcus 
faecium in Biofilm Formation, Adherence to Host Extracellular 
Matrix Components and Experimental Infection 
 
This chapter is based upon work in press in the journal Infection and Immunity with the 
same title as the one of this chapter (Infect Immun. 2016 Feb 29. pii: IAI.01396-15). I am 
co-first author of this publication (Montealegre MC, Singh KV, Somarajan S, Yadav P, 
Chang C, Spencer R, Sillanpää J, Ton-That, Murray BE) and I was responsible for 
preparing the original manuscript and conducted the majority of in-vitro experiments 
described; Dr. Singh, co-first author of this publication performed the in vivo 
experiments. ASM authors retain the right to reuse the full article in his/her dissertation 
or thesis. For further information visit http://journals.asm.org/site/misc/reprints.xhtml. 
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3.1. INTRODUCTION 
The genome of E. faecium TX16, also known as DO, encodes four PGCs predicted 
to form four distinct pilus-like structures (41-44). Indeed, the conditional expression of 
two distinct types of pili was demonstrated in an E. faecium hospital-acquired 
bloodstream isolate (43). In addition, differential assembly of the pilin proteins encoded 
by one of these pilin clusters, the PGC-1, has been observed between a bloodstream 
isolate and a community-derived stool isolate, with the latter strain only displaying the 
pilin proteins anchored to the cell wall, but not associated with pilus fibers (45).  
 
Another of these pilus clusters, the empABC operon (47), is enriched in isolates of 
clinical origin (90) and we had previously shown that, in the endocarditis-derived E. 
faecium strain TX82, allelic replacement of empABC (ΔempABC::cat) affected primary 
attachment and biofilm formation (47). In addition, we found that the ΔempABC::cat 
mutant was significantly attenuated, versus the parental strain TX82, in an experimental 
model of UTI (47). Furthermore, an epidemiological study found a significant association 
between the degree of biofilm formation and the presence of the empABC operon (91).  
 
The empABC operon is composed of three genes, encoding the structural subunit 
proteins EmpA, EmpB and EmpC; bps, encoding the class C sortase, is downstream of 
the empABC operon, separated by a predicted strong transcriptional terminator and 
shown to be transcribed independently (42, 47) (Figure 3.1). EmpC has been 
demonstrated to be the major pilin (42, 43, 47), while EmpA and EmpB are predicted to 
be incorporated into the fiber as minor components (47). However, the role of individual 
Emp pilus subunits in pilus-associated functions has not been explored previously. In 
this chapter, we investigated the contribution of each of the subunits of Emp to pilus 
architecture, biofilm formation, adherence to components of the ECM and infection. 
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Figure 3.1. Schematic representation of the emp operon of E. faecium TX82, its 
deletions derivatives and the empA reconstituted strain. 
The emp operon consist of three genes, empA, empB and empC, encoding the pilin 
subunits; bps, located after a predicted transcriptional terminator (indicated with a 
lollipop) downstream of empC, encodes a class C sortase. The genes deleted from each 
mutant are indicated and the silent mutation introduced in the empA reconstituted strain 
is indicated with an asterisk. Sudha Somarajan, Ph.D and Puja Sharma, Ph.D 
contributed to the generation of the deletion mutants. 
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3.2. MATERIAL AND METHODS 
Bacterial strains and growth conditions 
Relevant characteristics of the bacterial strains and plasmids used in this chapter 
are described in Table 3-1. E. coli strains, used for cloning experiments, were cultured at 
37°C in LB (BD) broth or agar. Enterococcus strains were routinely grown at 37°C using 
BHI (BD) broth or agar or TSB-G broth (BD). Ampicillin 100 μg/ml and gentamicin β5 
μg/ml were used for selection in E. coli, while gentamicin β00 μg/ml was used for 
enterococci. Enterococcosel agar (BD) supplemented with vancomycin (6 μg/ml) was 
used to grow the bacteria recovered from the animal experiments. Growth 
characteristics of TX82, its emp deletion derivatives and the empA reconstituted strain 
were assessed in BHI broth, by measuring the OD600 and by determining the number of 
CFUs on BHI agar, as previously described in chapter 2 and in (47).  
Construction of markerless deletions of empA, empB and empC genes and 
generation of an empA reconstituted strain (restoration of the empA gene in its 
native location)  
Non-polar deletions of the individual genes encoding the pilus subunits EmpA, 
EmpB and EmpC of E. faecium TX82 (Figure 3.1 & Table 3-1) were constructed using a 
previously described system (75), based on the pHOU1 vector (75, 76). Briefly, a 
fragment upstream and a fragment downstream of the genes to be deleted were 
amplified using the primers listed in Table 3-2. The two fragments flanking each gene 
were fused together by cross-over PCR, cloned into pGEM or TOPO vectors and sub-
cloned into pHOU1 (Table 3-1). 
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Table 3-1. Bacterial strains and plasmids used in chapter 3 
Strain or 
Plasmid Relevant Characteristic(s) Reference 
Strains 
  
E. faecium   
TX82 Endocarditis isolate. AMPR, VANR.  (92) 
TX5645 TX8β ΔempABC::cat; allelic replacement of empABC with 
cat (chloramphenicol acetyltransferase) gene. CHLR  
(47) 
TX6138 TX82 ΔempA; empA markerless deletion mutant. This study 
TX6139 TX82 ΔempB; empB markerless deletion mutant. This study 
TX6154 TX82 ΔempC; empC markerless deletion mutant. This study 
TX6152 TX6138::empA; TX82 ΔempA with empA reconstituted in 
situ in the chromosome. 
This study 
E. faecalis   
CK111 OG1Sp upp4::P23 repA4: conjugative donor that allows 
pHOU1 replication. 
(75) 
E. coli   
TG1 E coli host strain used for routine cloning  
DH5α E coli host strain used for routine cloning  
EC1000 E coli host strain for cloning of RepA-dependent plasmids (78) 
Plasmids 
  
pGEM-T Easy Plasmid used for initial cloning of PCR fragments. AMPR Promega 
Blunt II-TOPO Plasmid used for initial cloning of PCR fragments. KANR Invitrogen 
pHOU1 Conjugative donor plasmid that carries GENR and the 
counterselectable pheS* gene. 
(76) 
pQE30 Expression vector Qiagen 
pTEX5636 3192 pb fragment from TX16 empA (encoding mature 
EmpA without signal peptide or cell wall anchor domain) 
cloned into pQE30 expression vector. 
This study 
AMP, ampicillin; CHL, chloramphenicol; GEN, gentamicin; KAN, kanamycin VAN, vancomycin. 
Superscript “R” designates resistance. 
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Table 3-2. Oligonucleotides used in chapter 3. 
Primer 
Name Sequence 5- 3 Relevant Characteristics 
empA-UP-
F-NotI 
AATATGCGGCCGCGGAGTTCCTTG
GGATTCTCTC 
Forward for empA deletion (upstream 
fragment), NotI site underlined. 
empA-UP-R CAATCATCCCTACCGTCATTTTTCC
CCTCCTTTTTC 
Reverse for empA deletion (upstream 
fragment). 
empA-DW-
F 
GGAAAAATGACGGTAGGGATGATT
GGTTGTGCG 
Forward for empA deletion 
(downstream fragment). 
empA-DW-
R-PstI 
ATATCTGCAGGCCTTCTGTCAGCT
TTTCTCCATTCGATG 
Reverse for empA deletion 
(downstream fragment), PstI site 
underlined. 
empA-Rev-
F-NotI 
ATTGCGGCCGCAGAAGACCGGCT
GATGGAAA 
Forward for empA reconstituted strain, 
NotI site underlined. 
empA-Rev-
R-BamHI 
CGGGATCCAGGa*GGATCAGGGTA
GTCGT 
Reverse for empA reconstituted strain, 
BamHI site underlined. 
empAr-F GCGGGATCCGACACTACAGATGAT
CCAAC 
Forward for His6 tag expression of 
EmpA, BamHI site underlined 
empAr-R GCGGTCGACTTATGGTACTTTTGC
CTGATTCG 
Reverse for His6 tag expression of 
EmpA, SalI site underlined, translational 
stop codon in bold. 
empB-UP-
F-BamHI 
CGCTGGATCCCAGTCACTACTTCC
GATGATACG 
Forward for empB deletion (upstream 
fragment), BamHI site underlined. 
empB-UP-R TATACTGTCCGCCTCCATATTTAGC
TGCCCCCTCTTTC 
Reverse for empB deletion (upstream 
fragment). 
empB-DW-
F 
CAGCTAAATATGGAGGCGGACAGT
ATATTGAAAGTAGTC 
Forward for empB deletion 
(downstream fragment). 
empB-DW-
R-SmaI 
AATATCCCGGGTGATTAACGATCA
ACTG 
Reverse for empB deletion 
(downstream fragment), SmaI site 
underlined. 
empC-UP-
F-BamHI 
CGCGGATCCCCAAAGTACCAGAA
GTCGTC 
Forward for empC deletion (upstream 
fragment), BamHI site underlined. 
empC-UP-
R 
TGCACCGATATACACCATTTTTTCA
CTCCTGTTCT 
Reverse for empC deletion (upstream 
fragment). 
empC-DW-
F 
GAGTGAAAAAATGGTGTATATCGG
TGCAGGAGTAGT 
Forward for empC deletion 
(downstream fragment). 
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empC-DW-
R-EcoRI 
CCGGAATTCGAGTGTCCGTCCATT
GATTTC 
Reverse for empC downstream 
fragment, EcoRI site underlined. 
empC-F-
(RT) 
AGATAAAGGAGCGTCCGTGG Forward for empC, used for RT-PCR. 
empC-R-
(RT) 
AGCTGACACTCCGTCTTTTGG Reverse for empC, used for RT-PCR. 
fm-gyrA-F-
(RT) 
TATTACCTGGACCAGATTTTCCAA Forward for gyr, used for RT-PCR. 
fm-gyrA -R-
(RT) 
TTCTAAGATGTGTGCTCTTGCTTC Reverse for gyr, used for RT-PCR. 
*Silent mutation introduced to differentiate the empA reconstituted strain from TX82.  
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The recombinant pHOU1 plasmids were propagated in E. coli EC1000 and 
transferred to E. faecalis CK111 by electroporation (Table 3-1). Double-crossover 
homologous recombination was achieved by first transferring the plasmids into E. 
faecium TX82 through filter mating with E. faecalis CK111 carrying the recombinant 
plasmids, followed by culturing the gentamicin-resistant E. faecium colonies that 
integrated the plasmid on MM9YEG media supplemented with 10 mM p-Cl-Phe. Deletion 
of the genes was detected by PCR and confirmed by sequencing, with verification of the 
correct background by PFGE. For generation of the empA reconstituted strain (Figure 
3.1 & Table 3-1), a 4309 kb fragment that encompasses 439 bp upstream to 480 bp 
downstream of the empA gene was amplified from TX82 (a single silent mutation (Figure 
3.1 & Table 3-2) was introduced into the fragment, within the empB coding region, to 
differentiate this reconstituted strain from TX82) and cloned into the pHOU1 vector. 
Once the fragment was cloned into pHOU1, the approach described above for the 
generation of the deletions was followed to introduce in situ the empA gene into the 
chromosome of the ΔempA strain (Figure 3.1, TX6138).  
Reverse transcriptase PCR (RT-PCR) 
Total RNA from TX82 and the panel of deletion mutants was isolated from cells 
grown in TSB-G to mid-logarithmic phase (OD600~0.6). A 5 ml volume of the cultures was 
mixed with 10 ml of RNA protect reagent (Qiagen, Hilden, Germany), harvested and 
resuspended in 0.9 ml of TRIzol reagent (Ambion-Thermo Scientific, Waltham, MA). 
Cells were disrupted by bead beating for 1 min, twice, with cooling on ice in between 
(BioSpec Products, Bartlesville, OK). RNA extraction and purification was performed 
using PureLink RNA extraction kit (Ambion) following the manufacturer's instructions. 
cDNA was synthesized using SuperScriptIII First-Strand Synthesis System (Invitrogen, 
Carlsbad, CA). Primers, targeting an intragenic region of empC (Table 3-2), were used 
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to evaluate empC expression. Expression of the gene encoding gyrase A (gyrA) of E. 
faecium was used as an internal control (Table 3-2), as previously described (47). A 
PCR reaction, in the absence of reverse transcriptase, was used to assure the absence 
of genomic DNA in the RNA samples. 
Antibodies against EmpA 
Previously generated goat polyclonal antibodies were used to detect EmpC (42) 
while rabbit polyclonal antibodies against EmpA were generated in this study. The DNA 
sequence corresponding to amino acids 30 to 1093 of EmpA from the E. faecium strain 
TX16 (Table 3-2) was cloned into pQE30 (N-terminal His6-tag fusion) expression vector 
(42), generating the plasmid pTEX5636 (Table 3-1). Expression of rEmpA was induced 
with 1 mM IPTG and protein purification was performed by nickel affinity 
chromatography using His-GraviTrap columns (GE Healthcare, Uppsala, Sweden). 
Protein concentration was determined by absorption spectroscopy at 280 nm using 
calculated molar absorption coefficient values (93). Rabbit immunization with rEmpA 
was done following a pre-approved protocol and guidelines by the Animal Welfare 
Committee of the University of Texas Health Science Center at Houston. In brief, 1 mg 
of rEmpA in Freund’s complete adjuvant (FCA) was subcutaneously injected at multiple 
sites into a New Zealand white male adult (~3 kg) on day 1. Booster doses prepared in 
emulsified Freund’s incomplete adjuvant (FIA) were given subcutaneously at multiple 
sites on days 21 and 42. The animal was anesthetized prior to blood collection via 
cardiac puncture followed by euthanasia. Anti-EmpA antibody titers in rabbit sera were 
determined by enzyme-linked immunosorbent assay (ELISA) as previously described by 
(94) with some modifications. Briefly, 96-well plates (Immulon 4HBX, Thermo Fisher 
Scientific) coated overnight with 1 g of rEmpA in 50 mM carbonate-bicarbonate buffer, 
pH 9.6 were used to test the rabbit sera (serial dilutions from 1:200 to 1:25,600). 
  
52 
Detection was perform with peroxidase-conjugated anti-rabbit secondary antibody 
(Jackson ImmunoResearch Laboratories) and 1-Step™ PNPP substrate (Thermo Fisher 
Scientific). The highest serum dilution with an absorbance at 405 nm ≥ 0.10 at 3 min 
after addition of the substrate was the establish as the antibody titer (94).  
Immunoelectron microscopy 
Immunoelectron microscopy to study Emp pilus architecture in TX82 and its emp 
deletion mutants was performed as previously described (95), with minor modifications. 
Cells were grown in TSB-G to exponential phase, harvested by centrifugation and then 
washed with 0.1 M NaCl. Immunogold labeling was performed using the anti-EmpA and 
anti-EmpC antibodies described above, followed by 18 nm gold-conjugated goat anti-
rabbit IgG (1:20 dilution; Jackson ImmunoResearch Laboratories) for EmpA staining or 
12 nm donkey anti-goat IgG (1:20 dilution of 1 mg/ml; Jackson ImmunoResearch 
Laboratories) for EmpC staining. Samples were viewed using a Jeol 1400 transmission 
electron microscope.  
WC ELISA 
Surface display of EmpA and EmpC, using TX82, the panel of emp deletion mutants 
and the empA reconstituted strain, was measured at mid-logarithmic phase (OD600~0.6) 
by WC ELISA as described in chapter 2 and following a previously described 
methodology (32, 96). Rabbit and goat polyclonal antibodies (1:5,000 dilution of 1mg/ml) 
against EmpA (described above) and EmpC (previously generated in(42)), respectively 
were used as primary antibodies; while alkaline phosphatase conjugated F(ab’)β 
fragment goat anti-rabbit IgG and donkey anti-goat IgG (1:5,000 dilution; Jackson 
Immuno Research Laboratories) were added to the respective wells as secondary 
antibodies. Detection was performed by measuring the absorbance at 405 nm with a 
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microplate reader (Thermo Fisher Scientific) after the addition of 1-Step™ PNPP 
substrate (Thermo Fisher Scientific). 
Dot Blot 
Dot blot analysis was performed as described Konto-Ghiorhi et al. (87) with slight 
modifications. In brief, bacteria were grown in TSB-G to an OD600 of 0.6, harvested and 
washed twice with tris-buffered saline (TBS). The nitrocellulose membrane was spotted 
with approximately 2.3 x106 CFUs or 2.3 x105 CFUs, and then blocked with 5% skim 
milk in TBS. EmpC was detected with the goat anti-EmpC polyclonal antibodies (1:2,500 
dilution of 1mg/ml), followed by incubation with peroxidase mouse anti-goat IgG (H+L) 
(1:20,000 dilution; Jackson Immuno Research Laboratories). Detection was performed 
using the Super Signal West Pico Chemiluminescent Substrate (Thermo Fisher 
Scientific).  
Biofilm formation assay 
In vitro biofilm formation assay was performed as described in chapter 2 (96). In 
brief, E. faecium strains were grown overnight at 37°C in TSB-G broth and then diluted 
in the same media to an OD600 of 0.1, before inoculation into polystyrene plates (BD). 
Bacteria were allowed to grow for 24 h under static incubation at 37°C. The plates were 
gently washed three times with PBS, followed by treatment with Bouin’s fixative (Sigma-
Aldrich). After removing the fixative, the bacterial cells were washed with PBS and 
stained with 1% crystal violet solution (Sigma-Aldrich). Ethanol:acetone (80:20) was 
used to solubilize the dye and a microplate reader (Thermo Fisher Scientific) was used 
to measure the absorbance at 570 nm. 
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ECM binding assay  
Adherence to immobilized fibrinogen and collagen type I was assayed using a 
crystal violet based staining method as described previously (97) with the some 
modifications. In brief, Immulon HBX 4 plate wells (Thermo Fisher Scientific) were 
coated overnight with 10 μg/ml of the ECM proteins, followed by blocking unbound sites 
with 2% BSA in PBS for 1 h at RT. The E. faecium strains grown for 16 h at 37°C in BHI 
were collected by centrifugation, washed twice with PBS and resuspended in 1% BSA in 
PBS to an OD600 of 1.0. Bacteria were allowed to bind at 37°C for 2 h to the ECM coated 
wells, followed by two washes with PBS to remove unbound cells. Detection of the 
adherent cells was performed as described above for the biofilm formation assay. 
Mouse UTI model 
E. faecium TX82, its emp deletion derivatives and the empA reconstituted strain, 
were grown for 24 h in BHI broth, harvested and resuspended to equal OD600 in 0.9% 
saline solution
. 
The bacterial suspensions, estimated to contain 108 CFUs, were diluted 
1:10 and mixed together in an approx. 1:1 ratio (TX82 with each deletion mutant and 
ΔempA::empA with ΔempA).
 
In addition, serial dilution of the inoculum were made in 
0.9% saline and plated to determine the actual CFUs.
  
Six week-old female ICR mice 
were inoculated via intraurethral catheterization with the mixed bacterial suspension 
(approx. 106 CFU of each strain) and 48 h after infection, animals were euthanized and 
CFU counts were determined from kidneys and bladders by plating tissue homogenates 
onto Enterococcosel agar (BD) with vancomycin (6 μg/ml), as previously described (36). 
All colonies that grew (up to 47 CFU/organ) were picked into the wells of microtiter 
plates containing BHI broth + 15% glycerol, grown overnight and then replica plated onto 
Hybond™ -N+ membranes placed on BHI agar. After overnight growth on the 
membranes, colonies were lysated to perform high stringency hybridization (98), using 
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intragenic DNA probes of ddl and the corresponding emp gene. Hybridization results 
were used to generate the percentage of each strain recovered from the organs.  
Rat infective endocarditis model 
Aortic valve endocarditis was induced in male Sprague-Dawley rats by placement of 
a catheter across the valve, according to our previously published method (94). Twenty-
four hours after catheter placement, TX82 or the ΔempA deletion mutant (TX6138) 
grown 24 h at 37°C in BHI broth and resuspended in saline, were inoculated (i.v. via tail 
vein) into 16 rats. In addition, the inoculum was plated onto BHI agar to determine the 
actual CFU inoculated into the rats. Animals were euthanized 48 h after bacterial 
inoculation and hearts were ascetically removed. Establishment of bacterial endocarditis 
was confirmed at autopsy by evidence of vegetations formed around aortic valves and 
correct placement of the catheter across the valve. Vegetations together with the aortic 
valve were excised, weighed and homogenized in 1 ml saline. The homogenized tissue 
was plated on Enterococcosel agar (BD) with 6 μg/ml of vancomycin and colonies were 
counted after 48 h incubation at 37°C to determine the CFU per gram of vegetation. All 
the animal experiments described in this study were performed according to protocols 
used previously in our laboratory (36, 47, 94, 99), and following pre-approved protocol 
and guidelines by the Animal Welfare Committee of the University of Texas Health 
Science Center at Houston.  
Statistical analyses 
GraphPad Prism version 4.00 (GraphPad Sofware) was used for statistical 
analyses. Unpaired t-test was used to evaluate differences between the strains in the 
WC ELISA and biofilm formation assays. Analysis of variance (ANOVA) with 
Bonferroni’s multiple comparison post-test was used to compare the results from the 
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adherence assays. Differences in the length of pilus fibers produced by TX82 and the 
ΔempA were analyzed using unpaired t-test. Paired t-test was used to compare the 
percentage of bacteria recovered in kidneys and bladders versus the percentage of 
bacteria inoculated into the mice, while the Mann-Whitney test was used to analyze 
differences in the log10 CFU of TX82 versus the ΔempA deletion mutant recovered from 
vegetations.  
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3.3. RESULTS AND DISCUSSION 
E. faecium has rapidly emerged as a very important cause of hospital-associated 
infections (7). Different surface proteins, including pili, have been implicated in 
enterococcal pathogenesis (5, 100). The empABC operon is a three-gene locus (Figure 
3.1) that encodes a prototypical pilus structure that consists of a backbone pilin subunit, 
EmpC, and two minor accessory pilins, EmpA and EmpB (43, 47). In a previous study, 
we found that allelic replacement of the empABC operon from the endocarditis-derived 
isolate, TX82, led to significant attenuation in biofilm formation and in a mouse model of 
UTI (47); however, the role of the individual Emp pilus subunits to pilus-related functions 
has not yet been explored. Here, we sought to investigate the contribution of EmpA, 
EmpB and EmpC to pilus architecture, biofilm formation and adherence to components 
of the ECM and to the ability of E. faecium to cause infection. To address the function of 
each Emp pilus subunit, we individually deleted each gene of the emp operon from the 
endocarditis-derived E. faecium isolate TX8β (ΔempA, TX61γ8; ΔempB, TX6139; 
ΔempC, TX6154) (Figure 3.1 & Table 3-1). Deletions were designed to be unmarked 
and non-polar to avoid affecting the remaining pilin genes or the downstream gene, bps, 
that codes for a class C sortase. We also reconstituted in situ the empA gene into the 
chromosome of the ΔempA deletion strain (TX6138) to generate strain TX6152 (Figure 
3.1 & Table 3-1). Equivalent growth kinetics measured by OD600 (Figure 3.2) and 
comparable CFUs (data not shown) at all the time points tested were observed between 
the panel of deletion mutants, the empA reconstituted strain and the parental strain. 
  
  
58 
 
 
Figure 3.2. Growth curve of E. faecium, its isogenic emp deletion derivatives and 
the empA reconstituted strain. 
Strains were grown in BHI from an initial OD600 of 0.05 and samples were taken at 
indicated time points for OD600 measurements. 
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EmpA localizes at the tip of the fiber while EmpC is distributed along the length of 
the pilus shaft 
We analyzed pilus architecture in TX82 and its deletion derivatives by 
immunoelectron microscopy using antibodies generated against rEmpA and rEmpC 
proteins (EmpB localization was not studied since our previous study showed that the 
homolog of this subunit in E. faecalis, EbpB, was barely detectable by microscopy or WC 
ELISA (32)). EmpA is a VWA domain-containing protein predicted to be the tip pilin. As 
observed in Figure 3.3-A & Figure 3.3-C, EmpA localized at the tip of pilus-like 
structures; however, it was also abundantly seen on the surface, apparently not forming 
part of pilus polymers, on TX82 cells (Figure 3.3-A). In agreement with previous studies 
(42, 43, 47), our microscopy results confirmed EmpC as the major pilin, forming the 
backbone of the Emp pili (Figure 3.3-B, -C, -E & -G). As expected, the anti-EmpA 
antibody did not stain the ΔempA deletion strain (Figure 3.3-D). In contrast, in the 
ΔempB deletion strain, EmpA was observed on the bacterial surface and as the tip of 
pilus polymers (Figure 3.3-F), while in the ΔempC deletion strain, EmpA was only seen 
on the bacterial surface (not forming part of pilus polymers) (Figure 3.3-H). Importantly, 
deletion of empA or empB did not abrogate pilus polymerization, as pilus-like structures 
were seen with the anti-EmpC antibody on the ΔempA and ΔempB strains (Figure 3.3-E 
& -G); as expected, the anti-EmpC antibody did not stain the ΔempC deletion strain 
(Figure 3.3-I). 
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Figure 3.3. Immunoelectron microscopy analysis of pilus architecture in E. 
faecium TX82 and its deletion derivatives. 
Cells were grown to mid-log phase in TSB-G and stained with anti-EmpA and/or anti-
EmpC antibodies. (A) TX82 stained with anti-EmpA (18 nm); (B) TX82 stained with anti-
EmpC (12 nm); (C) TX82 stained with anti-EmpA (18 nm) and anti-EmpC (12 nm); (D) 
ΔempA stained with anti-EmpA (18 nm); (E) ΔempA stained with anti-EmpC (12 nm); (F) 
ΔempB stained with anti-EmpA (18 nm); (G) ΔempB stained with anti-EmpC (12 nm); 
(H) ΔempC stained with anti-EmpA (18 nm); (I) ΔempC stained with anti-EmpC (12 nm). 
Scale bars indicate a length of 0.β μm.  Dr. Chungyu Chang performed the majority of 
IEM. 
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EmpA is important for wild-type length of the pilus fiber 
Our electron microscopy experiments also provided evidence that the tip subunit, 
EmpA, is important for determining wild-type length of the pilus fiber. We measured the 
pilus lengths from 97 and 85 pilus fibers from TX8β and the ΔempA deletion strain, 
respectively, and found that deletion of the empA gene caused a significant increase in 
the length of the pilus fibers (Figure 3.3-E) compared to TX82 cells (Figure 3.3-B). The 
average length of pili produced by the ΔempA deletion strain was 1.22  0.76 μm (mean 
 standard deviation) versus 0.69  0.γ8 μm by TX8β (median for ΔempA, 1.0γ μm and 
for TX82, 0.69 μm, p < 0.0001; Figure 3.4). This is opposite to the shorter pilus fibers 
observed in Actinomyces oris when the tip subunit, fimQ, was deleted (101). In addition, 
we observed that deletion of empA caused a reduction in the number of pili per bacterial 
cell, which is in accordance with previous findings (101). In S. agalactiae, deletion of 
pilA, the first gene of the operon encoding the pilin adhesin, was associated with longer 
pilus fibers due to increase transcription of the downstream gene, pilB, encoding the 
shaft (87, 102). We observed only a slight increase in empC mRNA levels in the empA 
and empB deletion strains, compared to TX82, which suggests that increased 
expression of empC in the ΔempA deletion strain is probably not the sole cause of 
increased length of the pilus fibers in E. faecium (Figure 3.5). In contrast, in other Gram-
positive organisms, the levels of the shaft subunit have been implicated in the regulation 
of pilus length (103). While the underlying mechanism for the tip subunit’s control of pilus 
length remains to be determined, this result suggests important differences in the 
regulation of pilus assembly between enterococci and other Gram-positive bacteria. 
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Figure 3.4. Effect of empA deletion on pilus fiber length. 
Average pilus length (mean  standard deviation) from 97 and 85 pilus fibers from TX82 
and the ΔempA deletion strain, respectively. Statistical analysis was performed using the 
unpaired t-test. 
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Figure 3.5. Expression of empC measured by reverse transcriptase (RT)-PCR. 
 PCR amplification of empC (gel on top) and gyrA (gel on bottom; internal control) using 
10 ng of cDNA, 1 ng of cDNA or 10 ng of RNA of TX82 and the panel of emp deletion 
strains. Genomic DNA (gDNA) of TX82 and no template control (NTC) were used as 
controls of the PCR reaction. 
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Surface display of EmpA and EmpC by TX82, its isogeneic emp deletion mutant 
derivatives and the empA reconstituted strain 
We next investigated surface display of EmpA and EmpC by the single emp 
deletion mutants and the empA reconstituted strain in comparison to the parental strain, 
TX82, and the previously generated empABC operon deletion with cat gene allelic 
replacement (ΔempABC::cat) (47). WC ELISA, using our anti-EmpA antisera, revealed 
that this subunit is abundantly present on the surface of TX82 at mid-exponential phase 
(Figure 3.6-A). EmpC pilin was also displayed profusely on the surface of TX82 (Figure 
3.6-B), as previously demonstrated (47). Consistent with our earlier report (47), we did 
not detect EmpA or EmpC on the surface of the strain in which the emp operon was 
replaced with cat (ΔempABC::cat) (Figure 3.6-A & -B). In addition, and as anticipated, 
the ΔempA and ΔempC deletion strains did not express EmpA or EmpC on the surface, 
respectively (Figure 3.6). By WC ELISA we observed that deletion of empC and, to a 
minor extent, deletion of empB caused a significant reduction in EmpA surface display 
versus TX82 cells (p < 0.0001 and p = 0.0070, respectively; Figure 3.6-A). In addition, 
EmpC levels on the surface of the ΔempA deletion strain were significantly diminished (p 
< 0.0001), while deletion of the empB gene did not affect surface display of the shaft 
pilin subunit (p = 0.8404; Figure 3.6-B). No significant differences in EmpA and EmpC 
levels between TX82 and the empA reconstituted strain were observed, indicating 
restoration of pilin protein levels on the surface of the reconstituted strain (p = 0.7275 
and p = 0.4409, respectively; Figure 3.6).  
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Figure 3.6. Surface display of EmpA and EmpC by E. faecium TX82, its deletion 
derivatives and the empA reconstituted strain. 
Surface display of (A) EmpA and (B) EmpC detected by WC ELISA using polyclonal 
antibodies against EmpA and EmpC, respectively. Bars represent the mean ± standard 
deviation of the percentage of absorbance measured at 405 nm of each strain compared 
to TX82, from at least two independent experiments representing 10 wells per strain. 
Differences between TX82 and its derivatives were analyzed using t-test; p values are 
indicated in the figure. (C) Dot blot on whole bacteria (approximately 2.3 x106 CFUs or 
2.3 x105 CFUs of TX82 and its derivatives) using polyclonal antibodies against EmpC.  
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Since pili were shown to be longer in the ΔempA deletion strain, as compared to 
TX82, which is inconsistent with the reduced levels of EmpC seen on this strain by WC 
ELISA (Figure 3.6-B), we further evaluate the levels of EmpC on whole bacteria by an 
immunodot assay. As observed in Figure 3.6-C, a slight increase in EmpC (not a 
decrease as seen on WC ELISA), consistent with a slight increase at the mRNA level 
(Figure 3.5), was observed in the ΔempA deletion mutant compared to TX82 and the 
empA reconstituted strain. It is possible that the longer pili on the ΔempA deletion strain 
are more fragile and detach from the bacterial surface during the processing by WC-
ELISA. Furthermore, we observed a modest decrease in EmpC levels in the ΔempB 
deletion strain, probably due to release of pilus fibers, consistent with its role as pilus 
anchor (Figure 3.6; 32). These results, together with our electron microscopy studies, 
suggest that all the subunits of the pili are important for correct integrity of pilin fibers on 
the surface of E. faecium cells. 
EmpA is the main component of Emp pili that mediates biofilm formation 
In our previous study, we showed that allelic replacement of the empABC operon 
significantly affected biofilm, with a 75% reduction in biofilm formation in the 
ΔempABC::cat strain versus TX82 (47). Here, we investigated the contribution of each 
Emp pilus subunit to biofilm formation. As seen in Figure 3.7, deletion of empA reduced 
biofilm formation to the same extent as observed with the deletion of the operon, 
indicating that the tip subunit, EmpA, is the main component of the Emp pili mediating 
biofilm formation (p < 0.0001). In addition, when empA was reconstituted in situ, biofilm 
formation was restored (p > 0.05). 
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Figure 3.7. Contribution of each Emp pilin subunit to biofilm formation. 
Cells grown 24 h in TSB-G were analyzed for biofilm formation using a crystal violet 
based assay. Median values measured at 570 nm, interquartile ranges and minimum 
and maximum values (whiskers) from three independent experiments representing 30 
wells per strain are indicated. t-test was used to compare biofilm density values between 
TX82 and its derivatives; p values are indicated in the figure.  
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Surprisingly, we found the major backbone pilin, EmpC, to be dispensable for this 
process (p > 0.05), which is consistent with abundant EmpA seen in the surface of the 
ΔempC deletion strain (Figure 3.3-H); while deletion of empB led to a significant 
decrease in biofilm formation (p < 0.0001; Figure 3.7). These results indicate that EmpA 
and, to a lesser extent EmpB, play important roles in biofilm formation, even when the 
EmpC pili backbone is absent. 
EmpA and EmpB are important for adherence to ECM proteins 
Adherence to ECM proteins is proposed to be the first step in the infection process 
of E. faecium (104). Our group previously demonstrated, using a sensitive radioactive 
assay, that strain TX82 shows high levels of adherence to fibrinogen and collagen type I 
(104). Since pili in other Gram-positive organisms have been implicated in binding to 
ECM proteins (87, 88), including recent reports that demonstrated that EbpA of E. 
faecalis mediates adherence to host fibrinogen (69, 96), known to be exposed/released 
after trauma (69), our hypothesis was that Emp pili contributed to the adherence 
capacity of TX82. We investigated, by using a crystal violet based ECM binding assay, 
the involvement of each Emp pilus subunit to the adherence of E. faecium TX82 to 
fibrinogen and collagen type I. As observed in Figure 3.8, deletion of empA and empB 
significantly reduced fibrinogen (p < 0.001) and collagen I (p < 0.05 and p < 0.01, 
respectively) adherence compared to TX82, suggesting that these two subunits 
contribute to the adherence capacity of TX82. The empA reconstituted derivative 
showed almost wild-type levels of adherence (p > 0.05) and the ΔempC deletion strain 
showed no attenuation in binding; in fact, its fibrinogen binding ability was increased 
compared to TX82 (p < 0.01; Figure 3.8). 
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Figure 3.8. Contribution of each Emp pilin subunit to ECM adherence. 
Adherence of E. faecium TX82, its emp deletion derivatives and the empA reconstituted 
strain to immobilized (A) fibrinogen and (B) collagen type I. Bars represent the mean ± 
standard deviation of the percentage of adherence of each strain compared to TX82 
(defined as 100%) from four independent experiments representing 29 wells per strain. 
Statistical analysis was performed using ANOVA with Bonferroni’s post-test; p values 
are indicated in the figure. 
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In other Gram-positive organisms, including Corynebacterium diphtheriae, deletion 
of the gene encoding shaft subunit, also did not affect the adherence phenotype, 
although pilus assembly was abolished (105). The fact that deletion of empC showed an 
increase in binding is intriguing; one possibility is that, in the absence of EmpC, other 
cell wall-associated proteins, including EmpA, could have a closer or tighter interaction 
with components of the ECM. 
The three pilin subunits encoded by the emp operon are important in a mouse 
model of UTI 
In order to elucidate the role of the individual Emp pilin subunits in infection, we 
evaluated each of the deletion strains in a mouse model of UTI. We found that, after 48 
hours of infection, each of the deletion mutants were significantly attenuated in kidneys 
(p = 0.028 – p = 0.048) and in bladders (p < 0.0001 – p = 0.0124) versus TX82 (Figure 
3.9-A, -B & -C). These results indicate that EmpA, EmpB and EmpC are all require for 
full virulence of E. faecium TX82 in the UTI model. It is worth mentioning that, even 
though the empC deletion strain showed no attenuation in our in vitro assays (biofilm 
(Figure 3.7) and ECM adherence (Figure 3.8)), our in vivo model results demonstrated 
the importance of this subunit in the virulence of E. faecium (Figure 3.9-C). We also 
evaluated the empA reconstituted strain (ΔempA::empA) versus the ΔempA deletion 
mutant and found significantly higher percentage of the reconstituted strain, in kidneys (p 
= 0.0153) and bladders (p < 0.0008), compared to the empA deletion strain (Figure 3.9-
D), confirming the involvement of EmpA to E. faecium pathogenesis in UTI. 
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Figure 3.9. Attenuation of empA, empB and empC deletion mutants in a mouse UTI 
model, using a mixed inoculum. 
Mice were infected with a mixed bacterial suspension of TX82 and the (A) ΔempA 
deletion strain, (B) ΔempB deletion strain and (C) ΔempC deletion strain or (D) the 
empA reconstituted strain (ΔempA::empA) and ΔempA deletion strain. Horizontal lines 
represent the mean of percentage of total bacteria inoculated into each mouse and 
recovered 48 h after infection in kidneys and bladders. In some instances no bacteria 
were recovered (two in panel A (bladder) and one in panel C (kidney)). Results were 
analyzed using a paired t-test; p values are indicated in the figure.  
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Importance of EmpA in an endocarditis model 
EmpA has a VWA with a MIDAS motif. Given the demonstrated role of tip pilin 
proteins containing VWA domains in cell adhesion and pathogenesis (37, 86-88) and our 
result that implicated EmpA in biofilm formation, ECM adherence and UTI, our 
hypothesis was that this subunit plays an important role in endovascular infection. As 
shown in Figure 3.10, we found that after monoinoculation of TX82 and the ΔempA 
deletion mutant in a rat endocarditis model, the log10 CFUs of bacteria recovered from 
the vegetations were significantly lower in the rats inoculated with the empA deletion 
strain compared to TX82 (p = 0.0088; Figure 3.10), suggesting that EmpA is also 
important in the pathogenesis of endocarditis.  
 
Considering that the empABC operon is found in the majority of isolates of clinical 
origin (96 to 100%, depending on the clinical source), but is also frequently found in 
nonclinical isolates (73 and 77 % of fecal and animal isolates harbor the emp operon, 
respectively) (90), Emp pili represent an excellent target for vaccine development. In 
addition, success in preventing endocarditis infection by a monoclonal antibody that 
targets the Ebp pili of E. faecalis has been demonstrated (70). Furthermore, it was 
recently shown that immunization with EbpA, the counterpart of EmpA in E. faecalis, 
provides protection against catheter-associated bladder infection in mice (69). Our 
finding that EmpA is important for E. faecium biofilm formation, ECM adherence and 
infection suggests that this pilin subunit could be a potential target for the development 
of alternative therapeutic approaches to counteract this multidrug resistant pathogen.
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Figure 3.10. Effect of empA deletion in a rat model of infective endocarditis. 
Monoinfection experiment using 109 CFU inocula of TX8β or the ΔempA deletion strain. 
Data are expressed as log10 CFUs/g of bacteria recovered 48 h after infection from 
vegetations (horizontal lines represent the geometric mean CFU/g). Results were 
analyzed using the Mann-Whitney test; p value is indicated in the figure. 
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CHAPTER 4. Gastrointestinal Tract Colonization Dynamics by 
Different Enterococcus faecium Clades 
 
This chapter is based upon work published in The Journal of Infectious Diseases with 
the same title as the one of this chapter (J Infect Dis. 2015). I am co-first author of this 
publication (Montealegre MC, Singh KV, Murray BE) and I was responsible for 
preparing the original manuscript, conducted the in vitro competition experiments and 
participated in the in vivo experiments described; the in-vivo experiments were 
conducted by Dr. Singh, co-first author of this publication. A special acknowledgement to 
Karen Jacques-Palaz for her technical assistance. The right to include the article in full 
or in part in a thesis or dissertation, provided that this is not published commercially 
remains with the authors. For additional information visit 
http://www.oxfordjournals.org/en/help/faq/authors/online-licensing.html.  
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4.1. INTRODUCTION 
Different studies have demonstrated the existence of large differences in the 
accessory (51, 56, 59) and core genome (57, 59) between the E. faecium clades; 
however, very little is known about the factors that promote the predominance of 
subclade A1 strains in the hospital setting. Some have suggested that the transition of E. 
faecium from commensal to pathogen is a consequence of the enriched accessory 
genome of subclade A1 strains, including acquired antibiotic resistance determinants 
(106), genomic islands (56), and insertion sequences (55, 107). Putative virulence 
factors are also found to be enriched in subclade A1 strains (108); however, only a few 
of these have been experimentally proven to contribute to pathogenesis (109, 110). 
 
GIT colonization with antibiotic-resistant enterococci generally precedes infection 
(15). In addition, it has been demonstrated that during hospitalization, ampicillin-resistant 
E. faecium strains rapidly replace ampicillin-susceptible, commensal E. faecium strains 
(22, 111). Interestingly, after a patient is discharged from the hospital, ampicillin-resistant 
E. faecium tend to wane (111). Although the replacement of commensal clade B strains 
by subclade A1 E. faecium in the hospital environment could be related to greater 
fitness, colonization capacity or virulence potential of subclade A1 strains, our 
hypothesis is that commensal clade B strains have a better ability to colonize the GIT 
than clade A isolates, which would explain the vast predominance of clade B in humans 
in the community and why antibiotic-resistant E. faecium strains are often replaced once 
patients leave the hospital.  
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In an attempt to better understand the dynamics of E. faecium colonization, we 
evaluated the ability of 12 E. faecium strains from clades A1, A2 and B to colonize the 
GIT of mice, individually as well as in competition with a strain of a different clade. 
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4.2. MATERIALS AND METHODS 
Bacterial strains, routine growth conditions and general techniques 
E. faecium used from subclades A1 and A2 and clade B and their relevant 
characteristics are listed in Table 4-1, including five strains that grouped genetically into 
subclade A1, three strains from subclade A2 and four strains from clade B. The strains 
were chosen to cover a spectrum of ampicillin MICs and to represent different sequence 
types (STs; Table 4-1). PFGE was performed as previously described (112), with some 
modifications, to confirm that the strains selected were not closely related (data not 
shown). Isolates were routinely grown at 37°C using BHI broth or agar (BD). Mueller 
Hinton II broth (cation adjusted; BD) was used for susceptibility testing while 
enterococcosel agar (EA; BD) was used to grow bacteria recovered from animals.  
Susceptibility testing 
MICs of ampicillin (Sigma-Aldrich), erythromycin (Sigma-Aldrich), gentamicin 
(Sigma-Aldrich), and vancomycin (Sigma-Aldrich) were determined by broth 
microdilution according to Clinical and Laboratory Standards Institute (CLSI) guidelines. 
Murine GIT model 
GIT colonization studies used six-week-old female ICR mice (Harlan Laboratories). 
Mice were prescreened for enterococci before and after decolonization (Figure 4.1) by 
plating dilutions of fecal pellets on EA, a selective medium for enterococci, with 8 μg/ml 
of nitrofurantoin (EA-NIT8). We used a decolonization regimen, with some modifications, 
that has been previously used to successfully establish enterococci in the GIT of mice 
(18, 113, 114).   
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Table 4-1. E. faecium strains used in chapter 4 and MICs of selected antimicrobial 
agents. 
Clade Strain Name 
Source 
(isolation site) 
Country of 
Isolation/ 
Year 
STb 
MICsa (μg/ml) Refer
ence 
AMP ERY GEN VAN 
A1 
C68 
 
Hospitalized 
patient (feces) 
 
USA/1996 
 
16 128 >256 >1024 128 (115) 
1.230.933 
 
Hospitalized 
patient (blood)  
 
USA/2005 
 
18 128 >256 16 >256 (51) 
TX82 Endocarditis 
Patient (blood) 
 
USA/1999 
 
17 64 256 4 >256 (92) 
TX0133A 
 
Endocarditis 
Patient (blood) 
 
USA/2006 
 
17 64 >256 16 >256 (116) 
TX16 
(DO) 
 
Endocarditis 
Patient (blood) 
USA/1992 
 
18 
 
16 >256 16 0.5 (117) 
A2 
EnGen12 
 
Hospitalized 
patient  (ascites) 
NLD/1995 
 
27 
 
0.5 >256 16 >256 (59) 
EnGen35 
 
Hospitalized 
patient  (gut) 
NLD/1979 
 
66 1 4 8 0.5 (59) 
EnGen21 Hospitalized 
patient (feces) 
NLD/2002 5 
 
8 >256 8 >256 (59) 
B 
Com15 Healthy 
volunteer (feces) 
USA/2007 583 ≤ 0.β5 16 8 1 (51) 
TX1330 Healthy 
volunteer (feces) 
USA/1994 107 1 0.25 8 1 (118) 
E980 Healthy 
volunteer (feces) 
NLD/1998 94 ≤ β 32 8 0.5 (56) 
1.141.733 Hospitalized 
patient (wound) 
USA/2005 327 2 16 16 1 (51) 
a.AMP, ampicillin; ERY, erythromycin; GEN, gentamicin; VAN, vancomycin. b.Multi-locus 
sequence type. 
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Figure 4.1. Schematic representation of the GIT colonization mouse model used in 
this study. 
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In brief, five to seven mice per strain in mono-inoculation and four mice per 
combination in the competitions assays were first decolonized for four days with 1 mg/ml 
of gentamicin (113) in drinking water plus subcutaneous injections of clindamycin (2.4 
mg/day/mouse) (114). Antibiotics were stopped 24 h prior to gavage of bacteria, to allow 
elimination of drug (18) (Figure 4.1). Each strain was administered individually (for the 
mono-inoculation assays; Table 4-2) or in combination (for the competition assays) with 
a strain of a different clade (Table 4-3), in a suspension estimated by OD600 to contain 
approximately 107 to 109 CFUs; the actual number of CFUs was determined by plating 
serial dilutions of each inoculum made in 0.9% saline onto EA-NIT8 (all the E. faecium 
strains studied grew well on EA-NIT8; Table 4-2 & Table 4-3).  
 
Fresh stool pellets, one per mouse obtained by gentle abdominal massage, were 
collected directly in sterile pre-weighted Eppendorf tubes on days 2, 4, 7 and 10 or 14 
post-inoculation (Figure 4.1), weighted, serially diluted in 0.9% saline and plated EA-
NIT8. After incubation for 48 h at 37°C, E. faecium colonies were initially counted based 
on colony appearance; to further confirm their identity, 12 random colonies in the mono-
inoculation and 47 random colonies in the competition assays per animal and time point 
were picked and grown overnight in microtiter plates containing BHI broth plus 15% 
glycerol. The colonies were then replica plated onto Hybond™ -N+ membranes placed 
on BHI agar and, after overnight growth, bacteria were lysated for DNA hybridization 
under high-stringency conditions.  
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Table 4-2. Colony forming units (CFUs) in the inocula used in the in vivo mono-
inoculation experiments and presence (+) and absence (-) of markers used to 
distinguish the isolated colonies. 
Clade Strain Name 
Inoculum 
CFUs 
NITa ERYb VANc ddlEfm IS16 acm 
A1 
C68 2.3 x10
9
 
+ + + + + + 
1,230,933 4 x10
9
 
+ + + + + + 
TX82 1.4 x10
8
 
+ + + + + + 
TX0133A 2 x10
9
 
+ + + + + + 
TX16 (DO) 1.6 x109 + + + + + + 
A2 
EnGen12 5 x10
7
 
+ + + + - - 
EnGen35 3.3 x10
9
 
+ - - + - - 
EnGen21 5 x10
8
 
+ + + + - + 
B 
Com15 2.5 x10
9
 
+ - - + - + 
TX1330 2.2 x10
9
 
+ - - + - + 
E980 2.05 x109 + - - + - + 
1,141,733 3.6 x10
9
 
+ - - + - + 
a.
 EA with 8 μg/ml of nitrofurantoin, b. EA with 256 μg/ml of erythromycin, c. EA with 128 μg/ml of 
vancomycin 
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Table 4-3. Strain pairs and CFUs in the inocula used in the mixed inoculation 
experiments and antibiotics and probes used to differentiate the strains. 
 
Strain Pairs  
(Inoculum CFUs/ml) 
Used to differentiate the 
strains in the pairs (μg/ml) 
A1 vs. B A1 B 
 
1 C68 (4.3 x109) Com15 (2.95 x109) ERY (256), VAN (128), IS16 
2 TX82 (5 x107) Com15 (5 x107) ERY (256), VAN (128), IS16 
3 C68 (1.45 x109) TX1330 (2.3 x109) ERY (256), VAN (128), IS16 
4 TX16 (2.95 x109) E980 (2.75 x109) ERY (256), VAN (128), IS16 
A2 vs. B A2 B 
 
5 EnGen12 (1.1 x109) TX1330 (2.3 x109) ERY (256), VAN (128), acm 
6 EnGen35 (1.5 x108) Com15 (5 x107) acm 
7 EnGen21 (2.95 x109) E980 (2.75 x109) ERY (256), VAN (128) 
A1 vs. A2 A1 A2  
8 C68 (1.45 x109) EnGen12 (1.1 x109) IS16, acm 
9 TX82 (1.5 x108) EnGen35 (5x107) ERY (256), VAN (128) 
10 TX16 (2.95 x109) EnGen21 (2.95 x109) ERY (256), VAN (128) 
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Hybridization DNA probes for ddlEfm, for species confirmation (119). IS16 (107), 
present only in the subclade A1 strains and acm (120), absent from two A2 subclade 
isolates, were used for distinguishing the strains (Table 4-2 & Table 4-3). In addition, 
when antibiotic selection could be used (Table 4-1, Table 4-2 & Table 4-3), colonies 
were replica plated onto EA with 256 μg/ml of erythromycin and/or EA with 128 μg/ml of 
vancomycin. Results were used to calculate the number of CFUs/g (for the mono-
inoculation assays) and percentages of bacteria recovered (for the competition assays) 
from fecal pellets. PFGE was performed using random colonies from each experiment to 
confirm the strain identity (data not shown).  
Growth curves and in vitro competition assays 
To assess growth characteristics, bacteria from overnight cultures were inoculated 
at an initial OD600 of 0.05 and grown for 24 h at 37°C with gentle shaking. OD600 readings 
were taken every hour from 0 to 8 hours, with a final reading at 24 hours. In addition, 
aliquots were removed at 0, 2, 4, 8 and 24 hours for CFU determination on BHI agar 
(47). For the in vitro competition studies, we performed three independent replicates with 
three different strain pairs (two pairs A1 versus B and 1 pair involving A2 versus B). In 
brief, the strains grown individually overnight were inoculated at an approximately 1:1 
ratio into 10 ml of BHI broth and grown for 24 hours at 37°C with gentle shaking. At time 
0, 4 and 24 hours, samples were collected and serial dilutions as described above were 
plated onto BHI agar. To distinguish and obtain the percentage of each strain, at least 47 
colonies per time point were randomly selected and plated onto BHI and antibiotic 
selective plates (vancomycin 1β8 μg/ml and erythromycin β56 μg/ml) or hybridized with 
the acm probe, as described above for the in vivo competition (Table 4-3).  
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Statistical Analysis 
Statistical analyses were performed using GraphPad Prism version 4.00 (GraphPad 
Sofware). Differences in the geometric mean log10 CFUs/g from the mono-inoculation 
assays were evaluated using an unpaired t-test. Paired t-test was used to analyze the 
data from the in vitro and in vivo competition experiments, comparing the percentages of 
each strain recovered at different time points versus the percentages in the inoculum. 
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4.3. RESULTS 
Representatives of E. faecium clades colonize the GIT of mice at similar levels 
after mono-inoculation 
We studied 12 E. faecium strains, of which five grouped genetically into subclade 
A1, three were from subclade A2 (59), and four from clade B (Table 4-1); for clarity, the 
clade or subclade designation is at times written as a subscript. Compared with the 
clade B strains, the clade A strains generally showed higher MICs; of note, MICs ≥ 128 
μg/ml of erythromycin and vancomycin were only observed within clade A (Table 4-1). 
We first evaluated the effectiveness of antibiotic pre-treatment, previously used to 
facilitate colonization of enterococci by reducing the endogenous flora (18, 113, 114); as 
shown in Figure 4.2, this treatment was effective in reducing the load of bacteria. To 
assess clade-related differences in colonization capacity of the E. faecium strains, we 
next evaluated the ability of the 12 strains to colonize the GITs of mice after mono-
inoculation. The geometric mean log10 CFUs/g for each strain recovered from the fecal 
pellets are shown in Figure 4.3 (see also Figure 4.4 for detailed results). The greatest 
number of CFUs/g were observed at day 2, with most strains recovered in the range of 
108 to 109 CFUs/g, except TX82A1 (4.91 x 107 CFUs/g) and TX0133AA1 (1.51 x 107 
CFUs/g). As time progressed, the number of enterococcal CFUs found in the fecal 
pellets decreased, although the majority of strains were still present in high levels at day 
4 (between 107 to 109 CFUs/g), and counts of only TX0133AA1, TX1330B and E980B were 
below this range. At day 7, some strains were still present at high levels, including 
C68A1, 1.230.933A1 and TX16A1, EnGen12A2 and Com15B (range, 107 to 108 CFUs/g), 
while the others were recovered at lower levels (range, 103-106 CFUs/g).   
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Figure 4.2. Recovery of bacteria pre- and post-decolonization antibiotics. 
Log10 CFUs/g recovered from fecal pellets pre- and post-antibiotic decolonization 
treatment on EA-NIT8. Each symbol represents the log10 CFUs/g recovered from each of 
the 72 mice used in the mono-inoculation assays. The horizontal lines indicate the 
geometric mean log10 CFUs/g. 
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Figure 4.3. GIT colonization by the 12 E. faecium strains after mono-inoculation. 
Geometric mean log10 CFUs/g of each strain recovered from fecal pellets on days 2 to 
14 on EA with 8 μg/ml nitrofurantoin (EA-NIT8) after orogastric administration of (A) 
subclade A1 strains (1.4 x 108 – 4 x 109 CFU), (B) subclade A2 strains (5 x 107 – 3.3 x 
109 CFU) and (C) clade B strains (2.05 x 109 – 3.6 x 109 CFU) (see Table 4-2 for the 
inoculum counts of each strain). Each symbol represents the geometric mean CFUs/g 
recovered from fecal pellets of five to seven mice per strain (see Figure 4.4 for detailed 
results).  
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Figure 4.4. Detailed GIT colonization by the 12 E. faecium strains after mono-
inoculation.  
Log10 CFUs/g of each strain recovered from fecal pellets on days 2 to 14 on EA-NIT8 
after orogastric administration of (A) subclade A1 strains (1.4 x 108 – 4 x 109 CFU), (B) 
subclade A2 strains (5 x 107 – 3.3 x 109 CFU) and (C) clade B strains (2.05 x 109 – 3.6 x 
109 CFU) (see Table 4-2 for the inoculum counts of each strain). Each symbol represents 
the log10 CFUs/g recovered from fecal pellets of individual mice; the horizontal lines 
indicate the geometric mean log10 CFUs/g recovered of each strain. 
  
  
91 
All the strains, except TX0133AA1, were detected at day 14 after inoculation (Figure 
4.3 & Figure 4.4). To determine whether there were overall differences in the levels of 
colonization between the clades, we compared the composite geometric mean log10 
CFUs/g by clades and found no statistically significant difference in the colonization 
levels at any of the time points evaluated (p > 0.05; Figure 4.5). 
E. faecium clade B strains outcompete clade A strains as persistent colonizers of 
the GITs of mice when present together (competition assay) 
To access the effect on colonization of inoculating strains together, we again first 
pretreated mice as described above. Then, a bacterial suspension containing an 
approximately 1:1 ratio, based on OD600, of a strain from one clade and a strain from a 
different clade, were administered to the mice (Figure 4.1); the actual ratio was later 
determined by plating to assess the number of CFUs of each strain in the inoculum 
(Table 4-3). The results of in vivo competition assays are shown in Figure 4.6, Figure 4.7 
and Figure 4.8. When subclade A1 strains were evaluated with clade B strains (four 
different strain pairs tested; see Table 4-3), although the dynamics of colonization varied 
between pairs, in three of the four strain pairs tested, the commensal clade B strain 
significantly outcompeted the HA subclade A1 strain at day 14 (p < 0.0008 to 0.0118; 
Figure 4.6). Specifically, Com15B predominated over the subclade A1 strains C68A1 
(Figure 4.6-A) and TX82A1 (Figure 4.6-B); this difference was statistically significant at 
day 7 and 14 for both pairs and, for Com15B versus TX82A1, as early as day 2 (Figure 
4.6-B). Interestingly, TX1330B, although significantly outcompeted at early time points 
(days 2 and 4), eventually outcompeted C68A1 at days 7 and 14 (Figure 4.6-C). Only with 
TX16A1 versus E980B did the A1 strain predominate at all time points (Figure 4.6-D).  
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Figure 4.5. Aggregate GIT colonization by the different E. faecium clades after 
mono-inoculation of 12 strains. 
(A) Distribution of the numbers of bacteria recovered from fecal pellets on days 2 to 14 
on EA-NIT8 after orogastric administration of the 12 E. faecium strains. Each symbol 
represents the log10 CFUs/g recovered from fecal pellets of individual mice; the 
horizontal lines indicate the geometric mean log10 CFUs/g of all strains of each clade or 
subclade. (B) Composite comparison of numbers of bacteria by clades. Each symbol 
represents the geometric mean log10 CFUs/g recovered from fecal pellets of 30, 18 and 
24 mice, after orogastric administration of the subclade A1, subclade A2 and clade B 
strains, respectively.  
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Figure 4.6. GIT colonization by E. faecium subclade A1 versus clade B strains 
after mixed inoculation. 
Percentage of CFUs of subclade A1 versus clade B from the inoculum mix and from 
fecal pellets recovered at days 2, 4, 7 and 14 after mixed inoculation of the A1 versus B 
strain-pairs (A) C68 versus Com15, (B) TX82 versus Com15, (C) C68 versus TX1330 
and (D) TX16 versus E980. The horizontal lines indicate the means; the geometric mean 
log10 CFUs/g of total E. faecium recovered from fecal pellets on EA-NIT8 are indicated at 
the bottom of each graph below the “X” axes. The p values were calculated using paired 
t-test for the percentage of bacteria recovered in the fecal pellets versus that of the 
inoculum mix. 
 
  
  
95 
Competition between clade A2 and clade B was also evaluated using three different 
strains from each clade (three strain pairs were tested; see Table 4-3). With these pairs, 
we observed the predominance of the clade B strain over the clade A2 strains as early 
as day 2 (Figure 4.7); for the strain pairs EnGen35A2 versus Com15B (Figure 4.7-B) and 
EnGen21A2 versus E980B (Figure 4.7-C), this difference was significant from day 2 
onward, while TX1330B significantly predominated over EnGen12A2 from day 4 onward 
(p = 0.0092; Figure 4.7-A). These results support our hypothesis that, in the absence of 
concurrent antibiotics, when commensal clade B strains are present with clade A strains, 
the former are better able to persist as colonizers of GIT. 
 
We also asked whether differences in colonization exist when a strain of subclade 
A1 is co-inoculated with a strain of subclade A2 (Table 4-3). As depicted in Figure 4.8, in 
two of the three pairs evaluated, the subclade A1 strain outcompeted the subclade A2 
strain, whereas with one pair, EnGen35A2 predominated over TX82A1 at all time points 
(Figure 4.8). 
E. faecium clade B strains also predominated over the clade A strains in vitro  
The clear predominance of clade B strains versus clade A in the in vivo competition 
assays led us to study the in vitro growth of selected strains. When grown individually, 
the clade B strains studied, TX1330 and Com15, showed equivalent growth kinetics 
based on OD600 (data not shown) and CFU counts (Figure 4.9-A). In contrast, the 
subclade A1 strains, C68 and TX82, showed a slight and prominent growth delay, 
respectively, evidenced by decreased OD600 (data not shown) and CFU counts (Figure 
4.9-A).
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Figure 4.7. GIT colonization by E. faecium subclade A2 versus clade B strains 
after mixed inoculation. 
Percentage of CFUs of subclade A2 versus clade B from the inoculum mix and from 
fecal pellets recovered at days 2, 4, 7 and 14 after mixed inoculation of the A2 versus B 
strain pairs (A) EnGen12 versus TX1330, (B) EnGen35 versus Com15, (C) EnGen21 
versus E980. The horizontal lines indicate the means; the geometric mean log10 CFUs/g 
of total E. faecium recovered from fecal pellets on EA-NIT8 are indicated at the bottom 
of each graph below the “X” axes. The p values were calculated using paired t-test for 
the percentage of bacteria recovered in the fecal pellets versus that of the inoculum mix. 
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Figure 4.8. GIT colonization by E. faecium subclade A1 versus subclade A2 strains 
after mixed inoculation. 
Percentage (%) CFU of subclade A1 versus subclade A2 from the inoculum mix and 
from fecal pellets recovered at days 2, 4, 7 and 14 after mixed inoculation of the A2 
versus B strain-pairs (A) C68 versus EnGen12, (B) TX82 versus EnGen35 (C) TX16 
versus EnGen21. The horizontal lines indicate the means; the geometric mean log10 
CFUs/g of total E. faecium recovered from fecal pellets on EA-NIT8 are indicated at the 
bottom of each graph below the “X” axes. The p values were calculated using paired t-
test for the percentage of bacteria recovered in the fecal pellets versus that of the 
inoculum mix. 
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Figure 4.9. In vitro growth of subclade A1 and clade B E. faecium strains alone 
and in competition. 
(A) In vitro growth curves of strains C68A1, TX1330B, TX82A1 and Com15B. Bacteria were 
grown alone in BHI broth for 24 h at 37°C, and aliquots were removed at 0, 2, 4, 8 and 
24 h for CFU determination. In vitro growth competition of strains (B) C68 versus 
TX1330 and (C) TX82 versus Com15. Strains were inoculated at an approximately 1:1 
ratio into 10 ml of BHI broth and grown for 24 h at 37°C, aliquots were removed at 0, 4 
and 24 h and serial dilutions were plated on BHI agar. Each symbol represents the 
means percentage ± standard deviation from 3 independent experiments; p values were 
calculated using paired t-test. 
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In contrast, the subclade A1 strains, C68 and TX82, showed a slight and prominent 
growth delay, respectively, evidenced by decreased OD600 (data not shown) and CFU 
counts (Figure 4.9-A). Consistent with the growth kinetics of the individual strains, in in 
vitro growth competition, the clade B strains also predominated over the subclade A1 
strains (Figure 4.9-B & -C) and this difference was significant with the pair TX82A1 versus 
Com15B (6.6% versus 93.4% and 2.8% versus 97.2% at 4 h and 24 h, respectively) 
(Figure 4.9-C). When the subclade A2 strain (EnGen35)
 
and the clade B strain (Com15) 
were grown individually, similar growth kinetics at the earlier time points (2 and 4 h) were 
observed; however, EnGen35A2 had fewer CFU/ml than Com15B at the later time points 
(8 and 24 h; Figure 4.10-A). In the in vitro competition assay, a slight predominance of 
Com15B over EnGen35A2 was observed at 4 h, although almost equal percentages of 
each strain were present at 24 h (Figure 4.10-B). In summary, the differences seen in 
the in vitro competition growth generally mirrored the differences seen in growth curves 
when grown alone. That is, the clade B strain grew better than clade A strains when 
grown alone and they also grew better (outcompeted) the clade A strains when grown 
together. 
  
  
102 
 
Figure 4.10. In vitro growth of subclade A2 and clade B E. faecium strains alone 
and in competition. 
(A) In vitro growth curves of EnGen35A2 and Com15B. Bacteria were grown in BHI broth 
for 24 h at 37°C, and aliquots were removed at 0, 2, 4, 8 and 24 h for CFU 
determination. In vitro growth competition of strains (B) EnGen35A2 versus Com15B. 
Strains were inoculated at an approximately 1:1 ratio into 10 ml of BHI broth and grown 
for 24 h at 37°C, aliquots were removed at 0, 4 and 24 h and serial dilutions were plated 
on BHI agar. Each symbol represents the means percentage ± standard deviation from 3 
independent experiments; p values were calculated using paired t-test. 
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4.4. DISCUSSION 
GIT colonization and in particular intestinal overgrowth by antibiotic-resistant 
enterococci are recognized risk factors for infection (15). Clade B (CA) E. faecium are 
commonly found in healthy individuals but rarely cause infections; conversely, subclade 
A1 (HA) strains are responsible for the majority of infections and hospital outbreaks 
worldwide but are rarely reported colonizing healthy individuals in the community (57, 
59). The complex dynamics of GIT colonization by E. faecium and the different 
health/disease associations of the E. faecium clades prompted us to investigate the 
ability of representative E. faecium strains from each clade to colonize the GIT of mice. 
After administering each strain individually, we were able to establish all the strains, 
regardless of the clade, in the GITs of mice (Figure 4.3 & Figure 4.4); while the 
colonization dynamics varied between the strains, we did not find significant differences 
(Figure 4.5) in the ability of the clades to colonize the mouse GIT, as assessed by 
pooled CFU comparison. Interestingly, our in vitro growth curves, albeit with a limited 
number of strains, suggested a reduction in fitness for the clade A strains (Figure 4.9-A 
& Figure 4.10-A); however, this reduced growth in vitro of the clade A strains did not 
seem to parallel the density of the strain achieved in vivo after mono-inoculation (Figure 
4.3 & Figure 4.4), an outcome that is not unexpected since laboratory media do not 
replicate the complex conditions that bacteria may encounter in the GIT (e.g., availability 
of nutrients, host immune response and the presence of competitors). In addition, the 
fact that the pan-genome of E. faecium is predicted to be unlimited (56) suggests that a 
clade could acquire genes that have the potential to increase its fitness under certain 
environmental conditions; indeed, one gene cluster encoding a carbohydrate 
phosphotransferase system specifically enriched in isolates of clinical origin (clade A) 
was found important for GIT colonization during antibiotic treatment (121) (differential 
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use of carbohydrates has been suggested as one of the main drivers of the divergent 
evolution of the different E. faecium clades (59)). 
 
Since competition assays have been suggested to be more sensitive for measuring 
fitness (122), we also asked whether differences in the colonization capacity of the 
clades could be observed when a strain from one clade was co-inoculated into mice with 
a strain from a different clade. Interestingly, we observed predominance of the clade B 
strains over the clade A strains in six of the seven pairs tested (Figure 4.6 & Figure 4.7). 
In addition, the vitro competition assays also suggested a competition advantage of 
clade B strains over clade A strains (Figure 4.9-B-C & Figure 4.10-B), just as their 
growth also appeared better when grown alone, as mentioned above. What is surprising 
is that the in vivo mono-inoculation experiments did not show an in vivo difference when 
the strains were inoculated alone. Whether clade B strains, in competition, are better 
able to acquire nutrients, tolerate stress of the GIT, withstand host innate immune 
responses or directly suppress A1 strains is not known. In any case, these results 
support our hypothesis that clade B strains have a colonization advantage over clade A, 
at least in the absence of concurrent antibiotic treatment. This outcome is similar to 
findings from a recent study of E. faecalis, in which it was shown that a commensal 
isolate was more persistent than the nosocomial isolate in a murine GIT colonization 
model (123). A previous search for clade-specific orthologs (i.e. present in all isolates of 
one clade but absent in the other) revealed that the E. faecium clade B, but not clade A, 
harbors a set of genes that encode factors that could potentially mediate an interaction 
with eukaryotic cells, suggesting the possibility that clade B strains may be more closely 
associated with cells of the GIT than clade A strains (51). In addition, it is possible that 
the increased occurrence of resistance genes in clade A strains (Table 4-1), compared 
with clade B strains, could pose a fitness cost for the bacteria in the absence of 
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antibiotics, resulting in growth rate reduction and/or a decrease in their competitive 
ability in vivo and in vitro, as previously suggested (122, 124). Although we did not 
evaluate isogenic strains to determine the fitness cost of a particular resistance 
determinant, it is interesting to note that the only instance in which a subclade A1 strain 
outcompeted a clade B strain was when a vancomycin-susceptible subclade A1 strain, 
TX16 (DO), was in competition with the clade B strain, E980 (Figure 4.6-D). Indeed, the 
acquisition of VanA-type vancomycin resistance by enterococci (125) as well as in other 
species (126), has been associated with a substantial fitness cost. In addition, among 
the subclade A1 strains evaluated, TX16 showed the lowest MIC of ampicillin (Table 
4-1). The absence in TX16 of certain resistances associated with clade A1 strains (44, 
68) and its relatively early isolation suggest that this strain may have arisen early in the 
evolution of clade A1. 
 
In summary, we showed that clade B strains displayed an in vitro growth advantage 
over subclade A1 strains both when grown alone as well as when grown in mixed 
cultures. Interestingly, in vivo after mono-inoculation, subclade A1 strains showed no 
significant defect in their ability to colonize the GIT of mice, as they were recovered in 
approximately equal numbers to clade B and subclade A2 strains. However, we 
demonstrated the predominance of clade B strains over clade A strains in an in vivo 
competition model of GIT colonization, perhaps as a consequence of a direct 
antagonistic interaction between the strains or a better ability to compete for the same 
niche. These results appear to explain the vast predominance of clade B versus clade A 
in humans in the community and the observation that ampicillin- and vancomycin-
resistant E. faecium acquired during hospitalization diminish in number and seem to 
disappear with time after patients leave the hospital (22, 111, 127, 128), while 
commensal isolates seem to reemerge in these individuals.  
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CHAPTER 5. Differential Penicillin-Binding Protein 5 (PBP5) 
levels in the Enterococcus faecium Clades 
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5.1. INTRODUCTION 
Ampicillin-resistant E. faecium has emerged as one of the leading pathogens in the 
hospital setting (5, 7). In the USA, the incidence of infections caused by ampicillin-
resistant E. faecium started to increase during the 1980s, accompanied by a progressive 
increase in the ampicillin MICs over time (129, 130); currently, the majority of E. faecium 
isolated in hospitals around the USA are resistant to this ȕ-lactam antibiotic (5, 7), which 
has been mainly attributed to the presence of PBP5 (65, 129, 130). The proposed 
mechanism of PBP5-mediated action is its intrinsic low affinity for ȕ-lactam antibiotics, 
allowing peptidoglycan synthesis (transpeptidation) and bacterial growth when the other 
PBPs are inhibited by the drug (66, 67). 
 
High-level ampicillin resistance in clinical isolates of E. faecium has been primarily 
associated with variants of PBP5 with even lower affinity for ȕ-lactams (58, 68, 131-133). 
In particular, specific amino acid changes in the C-terminal transpeptidase domain of 
PBP5 have been implicated with increased ȕ-lactam MICs (58, 131, 132). A methionine-
to-threonine or alanine substitution at position 485 (Met-485-Thr/Ala) and the addition of 
aspartic acid or serine after amino acid 466 (Asp-466’ or Ser-466’), both positions 
located close to the active site of the enzyme, have been associated with the highest 
levels of resistance to ȕ-lactam antibiotics (58, 68, 132-134). In addition, other amino 
acid substitutions, including an alanine for isoleucine or threonine at position 499 (Ala-
499-Ile/Thr), a glutamine for valine at position 629 (Glu-629-Val) and a proline for serine 
at position 667 (Pro-667-Ser) have been implicated in resistance to ȕ-lactams (58, 68, 
132). Rice et al. demonstrated that single substitutions in positions 485, 499, 629 and 
466’ had low impact in the ampicillin MICs, but when these mutations were present in 
combination the levels of resistance were amplified (131). However, in clinical isolates, 
there is not an absolute correlation between these substitutions and high-levels of 
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ampicillin resistance (58). In addition, factors other than the PBP5 mutations, including 
increased PBP5 production, have been suggested to play a role in elevating the MICs of 
ampicillin and other ȕ-lactams (65, 135-137).  
 
Interestingly, the two main E. faecium lineages found in humans: the hospital-
associated clade (subclade A1) and the community-associated clade (clade B) (57, 59) 
differ in their ampicillin phenotype, which is attributed to the presence of two distinct 
allelic forms of the pbp5 gene that differ by approximately 5% (58). Most of the subclade 
A1 strains are resistant to ampicillin (MIC ≥ 16 μg/ml) and harbor the consensus pbp5-R 
allele, while the majority of clade B strains are susceptible to ampicillin (MIC ≤ 2 μg/ml) 
and harbor the consensus pbp5-S allele (58). In contrast, subclade A2 strains, 
associated primarily with animals and estimated to have split from subclade A1 75 years 
ago (59), were shown to display ampicillin MICs that range between 0.5 to 1β8 μg/ml, 
with the majority of isolates analyzed harboring a “hybrid-like” pbp5 (pbp5-S/R), 
considered an intermediate allele between pbp5-S and pbp5-R (68). It is interesting to 
note that, in addition to the amino acid changes in the transpeptidase domain of PBP5 
described above, the different pbp5 alleles have a number of other amino acid variations 
and silent polymorphisms throughout the PBP5 protein and pbp5 gene, respectively (58, 
68). 
 
On the basis of the observation that, in some clinical E. faecium isolates 
(presumably from subclade A1), increased amounts of PBP5 have been associated with 
elevated ȕ-lactams MICs, we postulated that differences in PBP5 levels exist between 
the E. faecium clades; in particular, we inferred that PBP5 protein levels are higher in 
clade A ampicillin-resistant strains compared to clade B and subclade A2 ampicillin-
susceptible strains. In this chapter, we examined PBP5 protein abundance by western 
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blot, as well as the genetic environment upstream of pbp5, from 16 E. faecium strains 
from clades A1, A2 and B that carry different variants of the pbp5 allele and cover the 
spectrum of ampicillin MICs.  
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5.2. MATERIALS AND METHODS 
Bacterial strains, plasmids, routine growth conditions and susceptibility testing 
Relevant characteristics of the E. faecium and E. coli strains used in this chapter 
are described in Table 5-1 and Table 5-2, respectively. E. faecium were routinely grown 
at 37°C in BHI broth or agar (BD). In some instances, the clade or subclade designation 
of the strains is written as a subscript. E. coli strains were cultured at 37°C using LB 
(BD) broth or agar. Ampicillin susceptibility testing was performed by broth microdilution 
in Mueller Hinton II broth (cation adjusted; BD) following the Clinical and Laboratory 
Standards Institute (CLSI) guidelines or by E-test (bioMérieux, Marcy-l’Étoile, France). 
Kanamycin (Sigma-Aldrich) 50 μg/ml was used for selection of E. coli with the 
pET28a(+) vector and derivatives. 
Expression and purification of soluble recombinant PBP5-S from Com15B and 
PBP5-R from C68A1  
 
Fragments of pbp5-S and pbp5-R were amplified from genomic DNA of the E. 
faecium strains Com15B and C68A1, respectively, using the primers F-rPBP5 and R-
rPBP5, containing the NdeI and BamHI restriction sites, respectively (Table 5-3). These 
fragments, lacking the first 108 bp of the pbp5 coding sequence that corresponds to the 
36 amino acids encoding the transmembrane domain, were cloned into the pET28a(+) 
vector using the NdeI and BamHI sites. The resulting recombinant plasmids, 
pTEX4302.1 (pbp5-S from Com15) and pTEX2193.1 (pbp5-R from C68), were 
propagated in E. coli TG1 cells and then transformed into E. coli BL21(DE3) cells for 
expression (Table 5-2).   
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Table 5-1. Relevant characteristics of the E. faecium strains used in chapter 5.   
Clade Strain Name 
Source 
(Isolation site) 
Country 
/Year ST
a
 
AMPb MIC 
(μg/ml) 
PBP5-S/R 
typec 
Refer
ence 
B 
Com15 Healthy volunteer 
(feces) 
USA/2007 583 0.19d S21/R0 (51) 
TX1330 Healthy volunteer 
(feces) 
USA/1994 107 1 S20/R1 (118) 
1.141.733 Hospitalized 
patient (wound) 
USA/2005 327 1 S20/R1 (51) 
TX2050 Unknown USA/1971 296 1 S20/R1 (138) 
E980 Healthy volunteer 
(feces) 
NLD/1998 94 1 S17/R4 (56) 
A2 
EnGen12 Hospitalized 
patient  (ascites) 
NLD/1995 
 
27 
 
0.5 S13/R8 (59) 
EnGen35 Hospitalized 
patient  (gut) 
NLD/1979 
 
66 1 S8/R13 (59) 
EnGen21 Hospitalized 
patient (feces) 
NLD/2002 5 8 S8/R13 (59) 
EnGen52 Hospitalized 
patient (blood) 
NLD/2002 332 128 S8/R13 (59) 
EnGen24 Hospitalized 
patient (urine) 
NLD/2001 210 32 S2/R19 (59) 
EnGen25 Hospitalized 
patient (stomach) 
NLD/1965 92 128 S0/R21 (59) 
A1 
TX16 
(DO) 
Endocarditis 
Patient (blood) 
USA/1992 18 
 
16 S4/R17 (117) 
TX82 Endocarditis 
Patient (blood) 
USA/1999 17 64 S1/R20 (92) 
C68 Hospitalized 
patient (feces) 
USA/1996 16 128 S1/R20 (115) 
1.230.933 Hospitalized 
patient (blood) 
USA/2005 
 
18 128 S1/R20 (51) 
1.231.502 Hospitalized 
patient (blood) 
USA/2005 203 128 S1/R20 (51) 
a.Multi-locus sequence type; b. Ampicillin; c.PBP5-S/R type as described by Pietta et al., indicating that X 
positions match the PBP5-S consensus and Y positions match the R consensus. d.MIC determined by E-test. 
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Table 5-2. Relevant characteristics of the E. coli strains and plasmids used in 
chapter 5. 
Strain or 
Plasmid Relevant Characteristic(s) Reference 
E. coli Strains 
  
TG1 Host strain used for routine cloning  
BL21 (DE3) Strain used for overexpression of recombinant 
PBP5.  
Life 
Technologies 
Plasmids 
  
pGEM-T Easy Plasmid used for initial cloning of PCR 
fragments; AMPR. 
Promega 
pET28a(+) Expression vector carrying T7lac promoter, adds 
an N-terminal His tag; KANR.  
Novagen 
pTEX4302.1 pET28a(+) derivative carrying a 1929 bp 
fragment of the pbp5-S gene from E. faecium 
Com15B. The fragment lacks the first 108 bp of 
the PBP5 coding sequence, which corresponds 
to the transmembrane domain region. 
This study 
pTEX2193.1 pET28a(+) derivative carrying a 1929 bp 
fragment of the pbp5-R gene from E. faecium 
C68A1. The fragment lacks the first 108 bp of the 
PBP5 coding sequence, which corresponds to 
the transmembrane domain region. 
This study 
AMP, Ampicillin; KAN, Kanamycin; Superscript “R” designates resistance. 
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Table 5-3. Oligonucleotides used in chapter 5. 
Primer 
Name Sequence 5’- 3’ Relevant Characteristics 
rPBP5 
  
F-rPBP5 GGAATTCCATATGCAAGAAA
CCCAAGCAGTA 
Forward for expression of Δ1-36 rPBP5; 
NdeI site underlined. 
R-rPBP5 CGGGATCCTTATTGATAATTT
TGGTTGAG 
Reverse for expression of Δ1-36 rPBP5; 
BamHI site underlined. 
pbp5 upstream region  
(These primers were designed to confirm the presence or absence of a 201 bp deletion 
upstream of pbp5) 
psr-F-del AGTATCCAAACGAACCTTCC Forward for psr; used to amplify the γ’ 
end of psr and the intergenic region 
between psr and pbp5. 
pbp5-R-del GCCTGTTCGATTTTTGCCG Reverse for pbp5; used to amplify the γ’ 
end of psr and intergenic region between 
psr and pbp5. 
pbp5 upstream region of  TX82A1 and 1.230.933 A1  
(These primers were designed based on the upstream region of pbp5 in the complete 
genome sequence of the E. faecium strain Aus0004) 
hisJ-F CCGTCACACCTTTTGCTTTT Forward for a gene encoding a putative 
histidinol phosphate phosphatase (HisJ); 
used with the pbp5-R115-134 primer. 
gnat-F TCAACGGCTCTATCTGCTCA 
 
Forward for a gene, gnat, encoding a 
putative acetyltransferase; used with the 
pbp5-R115-134 primer 
pbp5-R115-134 CCAGCTTCTACTGCTTGGGT Reverse for pbp5; used to amplify the 
region immediately upstream of pbp5. 
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E.coli BL21(DE3) harboring pTEX4302.1 and pTEX2193.1 plasmids were grown at 
γ7°C in LB medium containing 50 μg/ml kanamycin to mid-log phase. Expression was 
induced at 16°C by the addition of ß-d-1-thiogalactopyranoside to 0.4 mM and an 
additional incubation for 17 h. Purification was performed by a series of 
chromatographies1, as previously described with minor modifications (139). 
Generation of anti-rPBP5-S and anti-rPBP5-R antibodies2 
Polyclonal antibodies against rPBP5-S and rPBP5-R were separately generated 
using a previously described scheme (94, 140) and following a pre-approved protocol 
and guidelines by the Animal Welfare Committee of the University of Texas Health 
Science Center at Houston. In brief, male Sprague-Dawley rats were subcutaneously 
injected at multiple sites with 1 mg of rPBP5-S or rPBP5-R suspended in Freund’s 
complete adjuvant (FCA) at day 1, followed by two booster doses of 1 mg of rPBP5-S or 
rPBP5-R prepared in Freund’s incomplete adjuvant (FIA) at days 14 and β8. Blood was 
collected at day 42, followed by euthanasia of the animal. Antibody titers were 
determined by ELISA as previously described in chapter 3 and in (94). Prior to their use, 
anti-rPBP5-S and anti-rPBP5-R antibodies were absorbed with E. coli BL21(DE3) 
lysates to remove any anti-E. coli antibodies, if present.  
PBP5 detection by western blot  
Cells grown overnight in BHI broth were inoculated into fresh BHI broth at a starting 
optical density 600nm (OD600) of 0.05 and grown at 37°C with gentle shaking until 
reaching an OD600 of 1.1 ± 0.1. Cultures were centrifuged at 3900 rpm for 10 min and the 
                                               
 
1
 Dr. Milya G. Davlieva performed the PBP5 protein purification. 
2
 Dr. Kavindra V. Singh generated the polyclonal antibodies. 
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pellets were rapidly chilled on dry ice and stored at -80°C until used. Cells were 
resuspended in 1 ml of 1X PBS, disrupted twice by 1 min bead beating pulses at 
maximum speed, followed by centrifugation to recover the supernatant. Protein 
concentrations were measured using the Pierce Bicinchoninic Acid (BCA) Protein Assay 
Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. Samples, 
normalized to equal protein concentrations (19 μg), were boiled in SDS-containing 
sample buffer and separated by SDS-PAGE (10% acrylamide). Coomassie staining was 
used to ensure that equivalent amounts of protein were loaded into each lane (data not 
shown). Samples were transferred to a PVDF membrane (EMD Millipore, Darmstadt, 
Germany) and analyzed with the absorbed rat antisera against PBP5-S or PBP5-R, 
followed by incubation with peroxidase conjugated goat anti-rat IgG, light chain specific 
(Jackson Immuno Research Laboratories). As positive controls, 10 ng of purified 
recombinant PBP5-S and PBP5-R proteins were loaded into a lane. Intensity of the 
bands was analyzed using Image J software (http://imagej.nih.gov/ij/). 
Analyses of the genetic environment upstream of the pbp5 gene 
Whole genome sequences for 15 of the 16 strains included in this study were 
available in the NCBI website http://www.ncbi.nlm.nih.gov/genome and were used to 
retrieved the upstream region of pbp5. DNA and protein multiple sequence alignments 
were performed using the alignment tool MUSCLE from the EBI website 
http://www.ebi.ac.uk/Tools/msa/muscle/. Bioinformatic analyses were confirmed by PCR, 
using the primers listed in Table 5-3. 
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5.3. RESULTS AND DISCUSSION 
The 16 E. faecium strains, their ampicillin MICs and PBP5 types are shown in Table 
5-1. We used the PBP5 type designation (SXRY) described by Pietta et al. (68), based on 
the 21 positions previously reported to consistenly vary between PBP5-S and PBP5-R 
(58). Consistent with our previous reports, clade B strains showed ampicillin MICs ≤ 2 
μg/ml, subclade A1 strains displayed MICs ≥ 16 μg/ml, while the subclade A2 strains 
MICs ranged from 0.5 to 1β8 μg/ml (58, 68). It is important to note that, although two of 
the six subclade A2 strains studied have MICs of 1β8 μg/ml, they were chosen from 13 
Aβ strains with a median MIC of 4 μg/ml. 
 
Western blot, with a polyclonal serum raised against r-PBP5-S from Com15B, 
showed that PBP5 protein levels were higher in the ampicillin-resistant strains from 
clade A compared to those in the highly ampicillin-susceptible strains from clade B and 
subclade A2 (Figure 5.1). When PBP5 levels were detected with a polyclonal serum 
raised against r-PBP5-R from C68A, comparable results were obtained (Figure 5.2), 
indicating that differences observed between strains are due to differences in protein 
abundance and not in the affinity of the antibodies for a particular type of PBP5 ( Figure 
5.1 & Figure 5.2). Furthermore, comparable results were obtained in independent 
experiments (biological and technical replicates).  
 
When comparing strains of the same clade or subclade, we observed a correlation 
between the ampicillin MIC (Table 5-1), the PBP5 sequence type (Table 5-1) and the 
levels of PBP5 protein (Figure 5.1 & Figure 5.2)  
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Figure 5.1. Expression of PBP5 by western blot with polyclonal serum raised 
against rPBP5-S.  
Proteins were separated by SDS-PAGE, transferred to a PVDF membrane and PBP5 
was detected with a polyclonal serum raised against-r-PBP5-S from Com15 (see Figure 
5.2 for re-probed membrane with a polyclonal serum raised against rPBP5-R from strain 
C68). The E. faecium strains and ampicillin MICs are indicated above the image (See 
Table 5-1 for detailed description of the strains); 10 ng of recombinant PBP5-S and 
PBP5-R were loaded into the last two lanes as a control.  
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Figure 5.2. Expression of PBP5 by western blot with a polyclonal serum raised 
against rPBP5-R.  
Antibodies used to detect PBP5 in Figure 5.1 were removed and the membrane was re-
probed with a polyclonal serum raised against-r-PBP5-R from C68 (See  
Table 5-1 for detailed description of the strains). 
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Within subclade A1, TX16 (DO) displays moderate resistance to ampicillin (MIC = 
16 μg/ml) (58, 68), which correlates with its reduced PBP5 protein levels (Figure 5.1 & 
Figure 5.2) compared to the other subclade A1 strains studied with higher ampicillin 
MICs (MICs ≥ 64 μg/ml). However, in addition to its lower pbp5 expression compared to 
other subclade A1 strains, TX16 (PBP5-S4/R17) also lacks two amino acid changes 
(Asp/Ser-466’ and Met-485-Thr/Ala) that have been linked with the highest levels of 
ampicillin resistance (58, 68), which also could explain its moderate ampicillin MIC.  
 
When subclade A2 strains were compared to each other, higher PBP5 protein 
levels (Figure 5.1 & Figure 5.2) were observed in the strains with reduced ampicillin 
susceptibility (EnGen21, EnGen52, EnGen24 and EnGen25; MICs = 8-1β8 μg/ml) 
compared to the highly susceptible ones (EnGen12 and EnGen35; MICs = 0.5-1 μg/ml). 
Within subclade A2, we also analyzed three strains that displayed considerably different 
ampicillin MICs (EnGenγ5 = 1 μg/ml, EnGenβ1 = 8 μg/ml and EnGen5β = 1β8 μg/ml) but 
that have same number of amino acid changes (PBP-S8/R13) associated with the R form 
of the protein (EnGen35 and EnGen52 have the same amino acid sequence in these 21 
positions, while EnGen21 diverged in one position; Table 5-4). Interestingly, reduced 
PBP5 protein levels in EnGen35 may account for its very low MIC compared to 
EnGen21 and EnGen52 (Figure 5.1 & Figure 5.2). Conversely, PBP5 protein levels 
between EnGen21 and EnGen52 were comparable (Figure 5.1 & Figure 5.2), suggesting 
that other factors, including the seven amino acid differences (six outside of the 21 
consensus positions) between the PBP5 sequences of these two strains (68), could also 
play a role in the different ampicillin MICs (Table 5-4 & Table 5-5).  
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Table 5-4. Amino acid sequence in the 21 positions previously reported to vary between PBP5-S and PBP5-R of the E. 
faecium strains EnGen35A2, EnGen21 A2 and EnGen52 A2. 
Strain MIC (μg/ml) 
PBP5
-S/R 
type 
24 27 34 66 68 85 100 144 172 177 204 216 324 466' 485 496 499 525 586 629 667 
PBP5-S-
Consensus 
≤2   V S R G A E E K T L D A T - M N A E V E P 
EnGen35 1 S8/R13 A G Q E A E Q Q A I D S A - M K T D V E P 
EnGen21 8 S8/R13 A G Q E A E Q Q A I D S A - M K I* D V E P 
EnGen52 128 S8/R13 A G Q E A E Q Q A I D S A - M K T D V E P 
PBP5-R 
Consensus 
≥16  A G Q E T D Q Q A I G S A S A/T K T/I* D L V S 
*Isoleucine at position 499 is commonly found in strain from clade A2 with “hybrid-like” PBP5 sequences. 
Table 5-5. Amino acid changes outside the 21 positions previously reported to vary between PBP5-S and PBP5-R of the E. 
faecium strains EnGen35A2, EnGen21A2 and EnGen52A2. 
Strain MIC (μg/ml) 39 314 401 406 509 606 
PBP5-S-
Consensus 
≤2  T T A P D S 
EnGen35 1 N T A P D S 
EnGen21 8 T T S P D S 
EnGen52 128 N I A A E F 
PBP5-R 
Consensus ≥16 T T A P D S 
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When comparing clade B strains to each other, similar low PBP5 protein levels were 
observed between TX1γγ0, 1.141.7γγ and TXβ050 and E980 (MICs = 1 μg/ml), albeit 
the later showed a small decrease relative to the others; on the other hand, Com15 
showed a significant reduction in PBP5 quantity (the band was only visible when the film 
was overexposed) (Figure 5.1 & Figure 5.2), which is in accordance with its hyper-
susceptibility (MICs = 0.19 μg/ml; Table 1). 
 
The upstream region of pbp5 has been suggested to contribute to ampicillin 
resistance. Initial evidence for a role of this region comes from studies in E. hirae where 
an 87 bp deletion in the 5’ region of an open reading frame (ORF) located upstream of 
pbp5 was associated with increased PBP5 levels in a resistant mutant. This finding led 
to the designation of this ORF as penicillin-binding protein synthesis repressor (psr) 
(141); however, the direct role of Psr in pbp5 repression has not yet been established 
(142). Interestingly, Massida et al. showed that Psr is involved in the regulation of 
different cell surface-related processes in E. hirae including lysozyme sensitivity, 
autolysis, and the levels of rhamnose in the cell wall (143). Furthermore, a role for the 
pbp5 upstream region in the E. faecium subclade A1 strain, C68, was also shown (142). 
When the pbp5 gene of C68 was cloned along with its upstream region containing two 
ORFs, ftsW and psr, the ampicillin MICs were higher, compared to when the gene was 
cloned in the same vector with only its own promoter region (64-128 μg/ml versus 8-16 
μg/ml) (142). However, in strain C68, Psr seems not to participate in the regulation of 
pbp5 transcription (142). The role of the second ORF, ftsW, is unknown, but studies of a 
homologous gene in E. coli showed that the product of this gene is a transmembrane 
protein that interacts with PBP3 in E. coli (144). 
When I analyzed the sequence upstream of pbp5, in the 15 E. faecium strains with 
available whole genome sequences included in this study, a broad degree of genetic 
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variations, including large and small DNA fragment insertions and deletions, as well as 
single nucleotide polymorphisms (SNPs), was observed. Interestingly, we found some 
alterations in this upstream region that correlated with increased PBP5 abundance and 
ampicillin resistance. One of the changes associated with the highest ampicillin MICs is 
a 201 bp deletion that encompasses 137 bp of the γ’ end of psr and 64 bp of the 
intergenic region of psr and pbp5 (Figure 5.3). This deletion was confirmed by PCR, 
using the primers psr-F-del and pbp5-R-del that anneal on psr and pbp5, respectively, in 
five strains (EnGen52A2, Engen24A2, EnGen25A2, C68A1 and 1.231.502A1). Of note, four 
of the five strains with the highest ampicillin MIC (128 μg/ml) had this deletion (Figure 
5.4).  
 
In the remaining three resistant strains from subclade A1, TX16, TX82 and 
1.230.993 (MICs = 16-1β8 μg/ml) and in strain EnGen21 from subclade A2 (MIC = 8 
μg/ml), I found evidence of two major insertional events. In TX16A1 and EnGen21A2 
(MICs = 8-16 μg/ml), a 1346 bp fragment, that includes a 1179 pb transposase with 99% 
identity between these two strains, is inserted in the same exact position within the 
intergenic region of psr and pbp5 (Figure 5.5) (an insertion of this size was also 
visualized in the PCR shown in Figure 5.4).   
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Figure 5.3. Alignment of the upstream region of pbp5 from the E. faecium strains 
1.231.502A1, EnGen25A2, C68A1 and EnGen24A2 against TX1330B.   
The 201 bp region deleted is shown in blue (corresponding to 1γ7 bp of the γ’ end of 
psr) and in red (corresponding to the intergenic region between psr and pbp5). The 
transcriptional start site of the pbp5 gene, demonstrated by Rice et al. (142), and the 
predictive translational start codon are highlighted in yellow and green, respectively. The 
putative -10 and -35 boxes predicted in strain C68 are in bold and underlined (142). 
 
TX1330_B          TGCGGTATGGATTTCCTCAAAGACGATAATAAAAAGATCGATACATTATCCGTACCAGTA
1. 231. 502_A1      TGTGGTATGGATTTCCTCAAAGACA-----------------------------------
EnGen25_A2        TGTGGTATGGATTTCCTCAAAGACA-----------------------------------
C68_A1            TGTGGTATGGATTTCCTCAAAGACA-----------------------------------
EnGen24_A2        TGTGGTATGGATTTCCTCAAAGACA-----------------------------------
                  ** *********************                                    
TX1330_B          GACGGCAGTTGGGACTTCAACGACAATACGCCTTCCGGAAGTGTTCTGGAATTAGATTTG
1. 231. 502_A1      ------------------------------------------------------------
EnGen25_A2        ------------------------------------------------------------
C68_A1            ------------------------------------------------------------
Engen24_A2        ------------------------------------------------------------
                                                                              
TX1330_B          ACCAAAAACCAAGAAGCAATCAAAAAATTTCTGAATAATTAAGTAAAGAAAATAAAAGAA
1. 231. 502_A1      ------------------------------------------------------------
EnGen25_A2        ------------------------------------------------------------
C68_A1            ------------------------------------------------------------
EnGen24_A2        ------------------------------------------------------------
                                                                              
TX1330_B          AAGAAGTTAGAAATAACAATTTATGTTATGTTCTGACTTCTTTTATTATGTTAGAATAAA
1. 231. 502_A1      ----------------------------------------------TATGTTAGAATAAA
EnGen25_A2        ----------------------------------------------TATGTTAGAATAAA
C68_A1            ----------------------------------------------TATGT TAGAATAAA
EnGen24_A2        ----------------------------------------------TAT GTTAGAATAAA
                                                                **************
TX1330_B          CAGGTATAAATAGTGAAAATAAAGGAATAACAAGCAAAAGAAGGAGGAAAAAATGAAAAG
1. 231. 502_A1      CAGGTATAAATAGTG-AAATAAAGGAATGACAAGCAAGAGAAGGAGGAAAAAATGAAAAG
EnGen25_A2        CAGGTATAAATAGTG-AAATAAAGGAATGACAAGCAAGAGAAGGAGGAAAAAATGAAAAG
C68_A1            CAGGTATAAATAGTG-AAATAAAGGAATGACAAGCAAGAGAAGGAGGAAAAAATGAAAAG
EnGen24_A2        CAGGTATAAATAGTG-AAATAAAGGAATGACAAGCAAGAGAAGGAGGAAAAAATGAAAAG
                  *************** ************ ******** **********************
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Figure 5.4. PCR upstream of pbp5 using the primers psr-F-del and pbp5-R-del that 
anneal on psr and pbp5, respectively. 
The E. faecium strains and ampicillin MICs are indicated above the image (See Table 
5-1 for detailed description of the strains). The 201 bp deletion was confirmed in strains 
C68A1, 1.231.502A1, EnGen52A2, EnGen24A2 and EnGen25A2, while an insertion was 
detected in strains TX16A1 and EnGen21A2. In contrast, no PCR product was obtained 
for TX16A1, and 1.231.933A1.  
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TX1330_B        AGAAGTTAGAAATAACAATTTATGTTATGT------------------------------
EnGen21_A2      AGAAGTTAGAAATAACAATCTATGTTATGTTTTGACTTGAGAGTATAAAATATTTTGTGT
DO_A1           AGAAGTTAGAAATAACAATCTATGTTATGTTCTGACTTGAGAGTATAAAATATTTTGTGT
                ******************* **********                              
TX1330_B        ------------------------------------------------------------
EnGen21_A2      AAATGAAAAAATCCATACAAAAAAGGAAGTCCCTTCTGTAGAATAAAGTTAACGACAACC
DO_A1           AAATGAAAAAATCCATACAAAAAAGGAAGTCCCTTCTGTAGAATAAAGTTAACGACAACC
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      AATTCACAGAAAAGAGGACTTCCCTATGAATGATTTTACTACAGAAATTGTGCAAACTCT
DO_A1           AATTCACAGAAAAGAGGACTTCCCTATGAATGATTTTACTACAGAAATTGTGCAAACTCT
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      AGTCACTAAAGGCGATTTAAATGAATTATTCCGTTCGCACTTAGAAAAAGCGATAAACAC
DO_A1           AGTCACTAAAGGCGATTTAAATGAATTATTCCGTTCGCACTTAGAAAAAGCGATAAACAC
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      ACTCCTACGGACTGAATTAACGGCTTTTTTAGATTACGAAAAATATGATCGCACTGGTTT
DO_A1           ACTCCTACGGACTGAATTAACGGCTTTTTTAGATTACGAAAAATATGATCGCACTGGTTT
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      TAATTCAGGTAATTCGAGAAACGGTTCTTACTTTCGATCAATCAAAACCGAATATGGTGA
DO_A1           TAATTCAGGTAATTCGAGAAACGGTTCTTACTTTCGATCAATCAAAACCGAATATGGTGA
                                                                            
TX1330_B        - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EnGen21_A2      ATTAACATTGGAAATACCTAGAGATCGTAATGGTGAGTTTAAACAACAAACTTTACCAGC
DO_A1           ATTAACATTGGAAATACCTAGAGATCGTAATGGTGAGTTTAAACAACAAACTTTACCAGC
                                                                            
TX1330_B        - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EnGen21_A2      CTACAAAAGAACAAACGATACATTGGAAACCACTATTATCCATTTATTCGAAAAAGGTGT
DO_A1           CTACAAAAGAACAAACGATACATTGGAAACCACTATTATCCATTTATTCGAAAAAGGTGT
                                                                            
TX1330_B        - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EnGen21_A2      TACGATGTCTGAAATTGCTGATTTGATCGAAAAAATGTACGGTCATCACTATACTCCACA
DO_A1           TACGATGTCTGAAATTGCTGATTTGATCGAAAAAATGTACGGTCATCACTATACTCCACA
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      AACCATGTCCAACATGACTAAAGTTCTGACTGAAGAAGTAAATGCCTTTAAATCCAGAGC
DO_A1           AACCATGTCCAACATGACTAAAGTTCTGACTGAAGAAGTAAATGCCTTTAAATCCAGAGC
                                                                            
TX1330_B        - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EnGen21_A2      CTTAAATGATAAGTATGTCGCTATTTTTATGGACGCTACTTACATTCCACTAAAACGTCA
DO_A1           CTTAAATGATAAGTATGTCGCTATTTTTATGGACGCTACTTACATTCCACTAAAACGTCA
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TX1330_B        ------------------------------------------------------------
EnGen21_A2      AACTGTATCCAAAGAAGCGATTTATATTGCCATTGGTATACGAGAAGACGGCACTAAAGA
DO_A1           AACCGTATCCAAAGAAGCGATTTATATTGCCATTGGTATACGAGAAGACGGCACTAAAGA
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      AGTACTGAGTTATGCGATTGCTCCAACTGAATCAACATACGTTTGGAATGAGCTGCTACA
DO_A1           AGTACTGAGTTATGCGATTGCTCCAACTGAATCAACATACGTTTGGAATGAGCTGCTACA
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      GGATATTAACTCCAGAGGAGTTCAAGAAGTCTTGCTTTTTATTACGGACGGCTTAAAAGG
DO_A1           GGATATTAACTCCAGAGGAGTTCAAGAAGTCTTGCTTTTTATTACGGACGGCTTAAAAGG
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      CATGAAAGATACTATCCATCAAATTTATCCTAAAGCAAAATATCAGCATTGTTGTATCCA
DO_A1           CATGAAAGATACTATCCATCAAATTTATCCTAAAGCAAAATATCAGCATTGTTGTATCCA
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      TGTATCTCGTAATATCGCTCATAAAGTACGTGTCAAAGACCGAAAAGAAATCTGTGATGA
DO_A1           TGTATCTCGTAACATCGCTCATAAAGTACGTGTCAAAGACCGAAAAGAAATCTGTGATGA
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      CTTTAAGGCTGTTTATCAAGCTAACTCAAAAGAAGAAGCGAATACCTTCTTATCCGGCAT
DO_A1           CTTTAAGGCTGTTTATCAAGCTAACTCAAAAGAAGAAGCGAATACCTTCTTATCCGGCAT
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      GATTGAGAAATGGAAGAAAAACTATCCTAAAGTGACGCAGTCACTCATAGAAAACCAAGA
DO_A1           GATTGAGAAATGGAAGAAAAACTATCCTAAAGTGACGCAGTCACTCATAGAAAACCAAGA
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      CTTATTAACTTTTTATGATTTTCCACCTAGCATTCGTAGAACCATTTACTCAACCAATCT
DO_A1           CTTATTAACTTTTTATGATTTTCCACCTAGCATTCGTAGAACCATTTACTCAACCAATCT
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      AATCGAGTCTTTCAATAAGCAAATTAAAAGATACAGCCGTAGAAAAGAGCAGTTTCAAAA
DO_A1           AATCGAGTCTTTCAATAAGCAAATTAAAAGATACAGCCGTAGAAAAGAGCAGTTTCAAAA
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      TGAAGAATCACTAGAACGCTTTCTAGTCAGCATTTTTGATACATACAATCAAAAATTTCT
DO_A1           TGAAGAATCACTAGAACGCTTTCTAGTCAGCATTTTTGATACATACAATCAAAAATTTCT
                                                                            
TX1330_B        ------------------------------------------------------------
EnGen21_A2      AAACAGAAGCCATAAAGGTTTTCAACAGGTAACCGATACATTAGTTTCAATGTTTACTGA
DO_A1           AAACAGAAGCCATAAAGGTTTTCAACAGGTAACCGATACATTAGTTTCAATGTTTACTGA
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Figure 5.5. Alignment of the upstream region of pbp5 from the E. faecium strains 
EnGen21A2 and TX16 (DO)A1 against TX1330B. 
The transposase sequence is shown in red. The transcriptional start site of the pbp5 
gene, demonstrated by Rice et al. (142), and the translational start codon are highlighted 
in yellow and green, respectively. The putative -10 box predicted in strain C68 is in bold 
and underlined (142). 
  
                                                                            
TX1330_B        --------------------------------------------------------TCTG
EnGen21_A2      GTAACTAATTATTTTGCAGGAGGACAATTTATTTACACAAAATTATTGACGCTCCCTTTG
DO_A1           GTAACTAATTATTTTGCAGGAGGACAATTTATTTACACAAAATTATTGACGCTCCCTCTG
                                                                        * **
TX1330_B        ACTTCTTTTATTATGTTAGAATAAACAGGTATAAATAGTGAAAATAAAGGAATAACAAGC
EnGen21_A2      ACTTCTTTTATTATGTTAGAATAAACAGTTATAAATAGTGAAAATAAAGGAATGACAAGC
DO_A1           ACTTCTTTTATTATGTTAGAATAAACAGGTATAAATAGTG-AAATAAAGGAATGACAAGC
                **************************** *********** ************ ******
TX1330_B        AAAAGAAGGAGGAAAAAATGAAAAGAAGTGACAAGCACGGCAAAAATCGAACAGGCGCTT
EnGen21_A2      AAGAGAAGGAGGAAAAAATGAAAAGAAGTGACAAGCACGGCAAAAATCGAACAGGCGCTT
DO_A1           AAGAGAAGGAGGAAAAAATGAAAAGAAGTGACAAGCACGGCAAAAATCGAACAGGCGCTT
                ** *********************************************************
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On the other hand, no PCR product using the primer pair psr-F-del-pbp5-R-del was 
obtained for strains TX82A1 and 1.230.933A1 (MICs = 64-128 μg/ml) (Figure 5.4), which 
suggested a different genetic arrangement in the upstream region of these strains. When 
I analyzed the region upstream of pbp5 in the draft genome of TX82A1 and 1.230.933A1 a 
series of gaps in the sequence were detected; however, sequence alignments and PCR 
results, designed to close these gaps (Table 5-3), strongly suggest that the pbp5 
upstream sequence of these two strains is similar to the pbp5 upstream sequence of the 
subclade A1 strain, Aus0004 (data not shown). The region between the psr and the 
pbp5 gene in Aus0004 includes three different ORFs, ISEfm1, gnat and hisJ, predicted 
to encode a transposase, an acetyltransferase and a histidinol phosphate phosphatase, 
respectively (Figure 5.6). Of note, although these large deletion and insertional events 
likely affect the promoter region of pbp5, specifically the region upstream of the putative 
-10 sequence predicted by Rice et al. (142), we can not discard a role of Psr, since all 
the strains with ampicillin MICs ≥ 8 μg/ml had alterations in the sequence of the psr gene 
(data not shown) that could render this protein non-functional.  
 
In addition, I found several other small insertions, deletions and SNPs, between 
clades that could be associated with the differential expression of PBP5. A single 
nucleotide deletion between the demonstrated pbp5 transcriptional start (142) and the 
predicted ATG translational start was observed in clade A ampicillin-resistant strains 
versus clade B and subclade A2 ampicillin susceptible strains. In addition, a 5 bp 
deletion in the intergenic region of psr and pbp5 was observed in the clade A 
background compared to the clade B background (data not shown). In contrast, all the 
strains from clade B have a full-length psr gene located immediately upstream of pbp5 
and no deletions or insertions in the pbp5-psr intergenic region were observed.  
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Figure 5.6. Genetic environment of pbp5 in the E. faecium strain Aus0004. 
Three ORFs, ISEfm1, gnat and hisJ (shown in red), are located in between psr and pbp5 
and are predicted to code for a transposase, an acetyltransferase and a histidinol 
phosphate phosphatase of the HisJ family, respectively.  
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High-level ampicillin resistance in E. faecium has been primarily associated with 
sequence mutations in the transpeptidase domain of the low-affinity PBP5 (58, 68, 131-
133); however, earlier reports also pointed to increased production of PBP5 as a 
contributor to resistance, in particular in isolates with intermediate MICs (16 to 64 μg/ml) 
(65, 134, 135). Here, we found that ampicillin-resistant strains, including highly resistant 
strains with MICs > 64 μg/ml from subclades A1 and Aβ, showed higher PBP5 protein 
levels compared to ampicillin-susceptible clade B and subclade A2 strains (Figure 5.1 & 
Figure 5.2). This is in contrast to what was reported by Rybkine et al., who found an 
apparent decrease in PBP5 protein abundance in isolates with MICs greater than 16 
μg/ml (132). Conversely, our results are in accordance with previous findings by Fontana 
et al. that reported that the PBP5 protein levels in highly ampicillin-resistant strains are 
elevated (135). The controversial role of PBP5 overproduction in ampicillin resistance 
might be explained, at least in part, by the fact that most of the earlier studies used 
radiolabeled penicillin as a measure of PBP5 quantity, an experimental approach that 
also measures the ability of PBP5 to bind to the labeled compound (135), which has 
been shown to be decreased by the presence of specific PBP5 mutations (131).  
 
Overall, the results presented in this chapter provide further insight into PBP5-
mediated resistance, highlighting that, in addition to amino acid sequence alterations in 
PBP5, overproduction of this protein is also observed in highly resistant strains from 
clade A. In addition, this finding underscores the contribution of the clade background in 
the regulation of PBP5 abundance and points to differences in the upstream region of 
pbp5 as likely contributors to the differential levels of PBP5. Further studies are 
warranted in order to elucidate the underlying mechanism for the differential regulation of 
PBP5 levels between the E. faecium clades.   
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CHAPTER 6. CONCLUDING REMARKS AND FUTURE 
PERSPECTIVES 
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The rising clinical importance of members of the genus Enterococcus, primarily E. 
faecalis and E. faecium (5, 7), has prompted a number of investigations on factors that 
contribute to the pathogenesis and recent emergence of these organisms as important 
causes of infections. However, many aspects of the mechanisms used by enterococci to 
cause infections are still not understood. Considerable attention has been given to 
enterococcal surface proteins, including pili. The first part of this dissertation was 
focused on the Ebp pili of E. faecalis (Chapter 2) and its ortholog, the Emp, in E. 
faecium (Chapter 3). The work presented here indicates that Ebp and Emp pili display 
important differences in their regulation and function, despite the high homology 
between its subunits. Expression of the Ebp pili of E. faecalis seems more tightly 
controlled as compared to that of Emp pili of E. faecium. Studies in our lab have 
indicated that, after E. faecalis cells are grown in BHI media, less than 10% of the 
bacteria express pili on the surface (29). However, it has been demonstrated that the 
use of a different growth media, namely TSB-G, the addition of serum to BHI broth (BHI-
S) or the presence of bicarbonate, enhances Ebp surface display (29, 40). It is important 
to note that when transcript levels of the ebpABC operon were compared, no significant 
differences were observed under the different growth conditions studied (29). This 
finding suggested that regulation of Ebp levels on the surface under different growth 
conditions might occur post-transcriptionally. Different stages of the pilus biogenesis 
pathway could be subject to this regulation, including translation, secretion across the 
membrane, polymerization of the pilus fiber and/or anchoring of the pili to the bacterial 
cell wall (39).   
 
In Chapter 2 of this dissertation, I demonstrated that a non-canonical initiation 
codon, ATT, is used as the start of EbpA translation. This codon was found conserved in 
all E. faecalis isolates sequenced to date; in contrast, an ATG codon, at the equivalent 
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position, was predicted as the translational start of several EbpA orthologs in other 
enterococcal species, including E. faecium (96). The presence of this rare start codon as 
the start of EbpA protein synthesis downregulates the rates of EbpA translation, which in 
turns diminishes the levels of EbpA on the surface of the cells, compared to an 
engineered ATG start codon (96). Regulating the levels of EbpA exposed on the surface 
of the cells could be important for establishing a precise ratio between EbpA (the tip) and 
EbpC (the shaft) of the pilus fiber as, in principle, only one subunit of EbpA is required to 
initiate the polymerization of pilus fibers that contained multiple EbpC subunits (96). It 
would be interesting to address in future studies if the ratio of the Emp subunits is 
controlled in E. faecium and if so, the molecular mechanism underlying this regulation.   
 
Studies have demonstrated that downregulating the expression of immunogenic 
surface proteins could have positive effect for the bacterium in the context of human 
infections by diminishing the pressure exerted by the host immune system (89). By 
reducing the amount of EbpA on the surface, E. faecalis reduces its ability to form 
biofilms and adhere to fibrinogen (96); while these processes are important in the 
infection process, their reduction could potentially aid E. faecalis cells in dispersion to 
new sites and/or dissemination into the environment (96). Therefore, another interesting 
line for future research would be to establish if differences in the levels of pilation directly 
impact colonization and/or virulence using experimental animal models. 
 
Based on what it is known about the strength of Shine-Dalgarno (SD) sequence, the 
optimal spacing between the SD sequence and the start codon, and the adenine rich 
region upstream of the SD region (145, 146), we postulate that EbpA abundance is also 
fine-tuned by additional features in its mRNA. In this regard, we observed differences in 
the sequence and location of the SD sequence between ebpA and the other subunits of 
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the ebp operon (ebpB and ebpC), and between ebpA and its ortholog gene in E. 
faecium, empA, which could suggest that EbpA levels are further downregulated by 
additional mechanisms. 
 
In Chapter 3, fundamental insights into the function of the Emp subunits were 
presented. EmpA was shown to be located at the tip of the pilus fiber, but the vast 
majority was seen attached to the surface of E. faecium cells, presumably as monomers. 
In addition, it was found that, of the three subunits of Emp, EmpA is the most relevant 
subunit in biofilm formation and adherence to ECM proteins. These results are 
consistent with our previous findings on the tip subunit of the E. faecalis Ebp (32). 
Furthermore, we found that deletion of empA caused the production of very long pilus-
like structures, a phenomenon that was also observed by deletion of ebpA from E. 
faecalis (32). Since, in addition to longer pili, a marked reduction in the number of pilus 
fibers per bacterial cell was observed in our immunoelectron microscopy studies, one 
can predict that the availability of the tip subunits, EmpA and EbpA, in E. faecium and E. 
faecalis, respectively, may be important for efficient initiation of pilus polymerization. One 
possibility that could help explain the phenotype observed is that, when initiation of pilus 
polymerization occurs in the absence of a tip subunit, by a mechanism yet to be 
determined, pilus polymerization continues beyond typical wild-type lengths due to 
availability of the shaft subunit and reduction in the number of sites for initiation of pilus 
polymerization.  
 
The findings presented in Chapter 3 also show that EmpB, the base or anchor of 
the pilus fiber, is important for biofilm formation and ECM adherence, while EmpC, the 
shaft pilin of the Emp, is completely dispensable for these processes. This is different 
from our lab’s findings in E. faecalis, where deletion of ebpC, and not deletion of ebpB, 
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affected the ability of the cells to form biofilms, although this reduction was small in 
magnitude (32). Despite the fact that deletion of empC did not affect biofilm or ECM 
adherence in E. faecium, it was found that this subunit as well as the other Emp 
subunits, EmpA and EmpB, are important in a model of UTI. Furthermore, we provided 
evidence that EmpA is important for E. faecium pathogenicity in an endocarditis model. 
Overall, the results presented in Part I of this dissertation contribute to our 
understanding of pili regulation and function in enterococci. One can envision that 
targeting the tip subunit of the enterococcal pili, EbpA and EmpA, could be an excellent 
choice for vaccine or drug development in a pathogen characterized by high levels of 
resistance to the commonly used antibiotic therapies. Indeed, it has been demonstrated 
that vaccination with EbpA affects E. faecalis ability to form biofilm and to bind to 
fibrinogen and protects mice in a CAUTI model (69). Success in targeting the Ebp pili, by 
the use of a monoclonal antibody against EbpC, was also demonstrated by Pinkston et 
al. (70).  
 
In Part II, the focus shifted towards E. faecium. First, in Chapter 4, colonization by 
different strains that belong to the three known E. faecium clades (59) was explored. By 
using a mouse model, we found that, after monoinoculation of the strains, colonization 
was similar between the E. faecium clades; however, the in vitro growth of clade A 
strains was reduced relative to clade B strains (147). Interestingly, the dynamics 
observed when a strain from clade B was co-inoculated into the GIT with a strain of 
clade A reflects the colonization pattern seen in humans; that is, vast predominance of 
clade B in humans in the community and re-colonization of individuals who acquired 
clade A VRE nosocomially, with clade B strains soon after discharge from the hospital 
(22, 111, 127, 128). We found that, in six of seven in vivo co-inoculation experiments (A 
with B), clade B predominated over clade A, starting at day 2 in some pairs and after 14 
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days in all six pairs (147). In these experiments, in an attempt to resemble conditions in 
the community setting, no antibiotic treatment was given to the mice after they were fed 
with bacteria. One possible drawback of this study is that the colonization abilities of the 
strains in the murine model are not an accurate representation of the colonization 
abilities of the strains in humans; however, mice have been extensively used as a model 
organism for studying enterococcal colonization (15, 17, 121, 148-151). 
 
The mechanism underlying the predominance of clade B over clade A isolates when 
co-inoculated is currently unknown, and represents an interesting topic for future 
research. In E. faecalis, it was demonstrated that the multidrug resistant strain V583 was 
eradicated by E. faecalis commensals of the GIT bacterial consortium, by a mechanism 
that involves pheromone responsive plasmids (152). On the other hand, Kommineni et 
al. showed that the production of an enterococcal bacteriocin (bac-21), encoded in a 
sex-pheromone responsive plasmid (pPD1), confers a competitive advantage to E. 
faecalis compared to enterococci indigenous of the mouse GIT or to an E. faecalis strain 
lacking pPD1 (153). Preliminary evidence suggests that, in the majority of the E. faecium 
strain pairs we studied, killing of the hospital strain by the commensal strain is not the 
reason why commensal strains predominated. Therefore, it is more likely that clade B 
strains are better able to compete for resources or for a niche, or that they have 
enhanced ability to cope with conditions in the gut, including the host immune system 
and/or the thousands of other organisms present in this environment. It also would be 
interesting to investigate if clade A and clade B colonize the same niche of the GIT. On 
this subject, it was recently shown that vancomycin-resistant E. faecium co-localize in 
the same region of the colon with another important nosocomial pathogen, Klebsiella 
pneumoniae, but most likely they reside in separate niches (154). 
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Another interesting line of investigation would be to address the effect of concurrent 
antibiotic treatment on the ability of the clades to colonize the GIT of mice, in order to 
investigate if the dynamics seen in the absence of antibiotics change upon antibiotic 
therapy. Since clade A strains display higher levels of resistance compared to clade B 
strains, we believe that antibiotic treatment would give the clade A isolates a fitness 
advantage over clade B isolates and other bacterial species of the microbiota that will 
impact the colonization dynamics. Although this prediction may seem obvious, it is 
complicated by parenteral delivery of antibiotics, which may or may not reach 
concentrations in the gut sufficient to inhibit other bacteria or select for one clade versus 
the other. Indeed, evaluating the effect of parenteral cephalosporin therapy, which is 
commonly used in the clinical setting, on the colonization dynamics of the E. faecium 
clades would be of high clinical relevance, since this therapy is associated with 
increased risk of developing enterococcal infections at variety of sites (155). In addition, 
it has been demonstrated that treatment with third-generation cephalosporins, such as 
ceftriaxone, preceded E. faecium overgrowth in 93% of patients (156).  
 
Overall, the results presented in Chapter 4 advanced our knowledge about the 
complex dynamics of GIT colonization by the E. faecium clades and open new avenues 
for future research aimed at deciphering the factors that contribute to the emergence of 
E. faecium as a prominent pathogen in the hospital environment. By understanding the 
reasons that promote E. faecium colonization, we could increase our capacity to identify 
individuals at risk for development of infections. These studies could also potentially lead 
to the design of therapeutic strategies aimed at diminishing intestinal colonization, which 
in turn should translate into decreased rates of infections.  
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In Chapter 5, the focus was on one core gene, pbp5, which shows sequence 
variation between the E. faecium clades. Previous studies have demonstrated that the 
distinct allelic types of pbp5, pbp5-S and pbp5-R, are associated with susceptibility and 
resistance to ampicillin, respectively; however, sequence differences alone could not 
explain the array of different ampicillin MICs seen in E. faecium (58, 68). The results 
presented in this chapter indicate that, in addition to different pbp5 allelic types carried 
by the E. faecium clades, there are marked differences in PBP5 abundance that, in the 
majority of the strains, correlate with their ampicillin phenotype. Furthermore, we 
presented evidence of the extensive differences in the region upstream of the pbp5 gene 
among the strains studied that may account for the differential abundance of PBP5. 
Considering that ȕ-lactam resistance in E. faecium is a worldwide therapeutic problem, it 
will be of significant clinical interest to investigate the mechanism by which PBP5 levels 
are up-regulated in clade A resistant strains versus clade B/A2 susceptible strains.  
 
In some instances, however, neither the PBP5 type nor its protein levels could 
account for the ampicillin MICs, which suggests that additional factors contribute to the 
differences in the ampicillin phenotypes among clinical isolates of E. faecium. In this 
regard, Zhang et al., using a transposon mutant library, identified a number of genes 
associated with ampicillin resistance (157). In that study, by the generation of non-polar 
markerless deletions or by disrupting the coding sequence using an insertional 
approach, it was found that three genes with roles in cell wall biogenesis, ddcP, ldtfm and 
pgt, can contribute to ampicillin resistance in E. faecium (157). One could further 
investigate if differences in the sequence and/or expression levels of these recently 
identified ampicillin determinants could explain the yet unaccountable differences in the 
ampicillin MICs between certain E. faecium isolates. In addition, it is possible that other 
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factors could mediate activation or repression of PBP5 function or that PBP5 works in 
concert with other proteins to mediate resistance.  
 
Taken together, the work presented in this dissertation offers important 
contributions to the understanding of the enterococcal pili including a mechanism that is 
part of the complex regulatory network that controls Ebp pilus expression in E. faecalis 
and the role that the Emp pili play in the pathogenesis of E. faecium infections. 
Furthermore, this work begins to shed light on the colonization dynamics of the E. 
faecium clades and also addresses how differences in the PBP5 levels between the 
clades are linked to the differential resistance to ampicillin. Overall, the results presented 
here are likely to lead to interesting future studies that could help explain why 
enterococci, in particular E. faecium, has recently become a more frequent cause of 
infections in hospitals.  
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